Evaluating metal bioaccessibility of soils and foods using the SHIME by Laird, Brian Douglas
EVALUATING METAL BIOACCESSIBILITY OF  
SOILS AND FOODS USING THE SHIME  
 
 
A Thesis Submitted to the College of 
Graduate Studies and Research 
In Partial Fulfillment of the Requirements 
For the Degree of Doctor of Philosophy 
In the Toxicology Graduate Program 
University of Saskatchewan 
Saskatoon 
 
By 
 
BRIAN DOUGLAS LAIRD 
 
 
 
 
 
© Copyright Brian Douglas Laird, September, 2010. All rights reserved. 
 PERMISSION TO USE 
In presenting this thesis in partial fulfilment of the requirements for a Postgraduate degree from 
the University of Saskatchewan, I agree that the Libraries of this University may make it freely 
available for inspection.  I further agree that permission for copying of this thesis in any manner, 
in whole or in part, for scholarly purposes may be granted by the professor or professors who 
supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the 
College in which my thesis work was done.  It is understood that any copying or publication or 
use of this thesis or parts thereof for financial gain shall not be allowed without my written 
permission.  It is also understood that due recognition shall be given to me and to the University 
of Saskatchewan in any scholarly use which may be made of any material in my thesis. 
 
 Requests for permission to copy or to make other use of material in this thesis in whole or 
part should be addressed to: 
 
 
Dr Barry Blakley 
Graduate Program of Toxicology, Program Chair 
University of Saskatchewan 
Saskatoon, Saskatchewan  S7N 5B3 
 
 
 
 
 
i 
 ABSTRACT 
Ingestion exposure estimates typically use a default bioavailability of 100%, thereby 
assuming that the entirety of an ingested dose is absorbed into systemic circulation. However, the 
actual bioavailability of ingested contaminants is oftentimes lower than 100%. The research 
described herein investigates the use of the Simulator of the Human Intestinal Microbial 
Ecosystem (SHIME) for the calculation of in vitro bioaccessibility (IVBA), a conservative 
predictor of bioavailability, of mercury (Hg) from traditional northern foods and arsenic (As) 
from soils. The primary objective of the research described herein is to address data-gaps which 
have hindered attempts to incorporate IVBA into risk assessment on more than a case-by-case 
basis. The hypotheses of this thesis are that (1) the bioaccessibility of contaminants is dependent 
upon concentration due to kinetic limitations on dissolution, (2) gastrointestinal (GI) microbes in 
the ileum and colon alter contaminant bioaccessibility and/or speciation, (3) the GI microbial 
effect on bioaccessibility is toxicologically relevant, and (4) metal bioaccessibility is predictable 
according to dissolution kinetics.  
Mercury bioaccessibility from country food samples was independent of total Hg 
concentration (F=0.5726, P=0.578) whereas As bioaccessibility was inversely related to total As 
concentration for Nova Scotia mine tailings, synthesized ferrihydrite with adsorbed AsV, and 
synthesized amorphous scorodite (P=2 x 10-10). Isotherm analysis indicated that, at high soil As 
concentrations, saturation of simulated GI fluids limited As bioaccessibility under gastric 
conditions whereas kinetic limitations constrained As bioaccessibility under intestinal conditions. 
Additionally, we demonstrated that GI microbes may affect Hg bioaccessibility, either increasing 
or decreasing bioaccessibility depending upon the type of food.  For example, the 
bioaccessibility of HgT decreased in the presence of GI microbial activity for caribou kidney, 
caribou tongue, seal blood, seal brain, seal liver, and walrus flesh. In contrast, HgT 
ii 
 bioaccessibility from Arctic char and seal intestine increased in the presence of GI microbial 
activity. Similarly, colon microbial activity increased (Fishers Protected LSD, P<0.05) As 
bioaccessibility from synthesized amorphous scorodite (56 – 110%), Nova Scotia mine tailings 
(140 – 300%), an agricultural soil (53%) and an ironstone soil (350%) containing elevated 
arsenic concentrations. However, under small intestinal conditions, this microbial effect was 
transient and demonstrated a small effect size.  
The toxicological relevance of microbial effects upon As bioaccessibility was assessed using 
a juvenile swine model with co-administration of oral antibiotics (neomycin and metronidazole). 
This study research indicated that microbial effects on As bioaccessibility are not reflected in the 
juvenile swine model. For example, the microbial communities present in the pig’s proximal 
colon clustered according to antibiotic treatment (e.g. microbial communities of antibiotic treated 
pigs differed from non-treated pigs). Despite this, the urinary arsenic excretion (and hence 
arsenic bioavailability) of antibiotic-treated juvenile swine orally exposed to soil-borne arsenic 
was equivalent (Holm-Sidak, P=0.930) to the urinary arsenic excretion of juvenile swine not 
treated with antibiotics. Therefore, in vitro GI models may not need to include a microbially 
active intestinal stage when measuring As IVBA.  
Metal bioaccessibility from soils appears predictable according to fundamental chemical 
properties of the metal-of-concern. Specifically, metal bioaccessibility of 7 of the 13 metals (V, 
Ni, Zn, Cu, U, Cd, & Ba but not Tl, Pb, As, Se, Cr, and Hg) regulated according to Canadian 
Council of Ministers of the Environment Soil Quality Guidelines (CCME SQG) were strongly 
dependent (R2 = 0.7) on water exchange rate constants of metal cations (kH20) indicating that 
desorption kinetics may serve as the foundation of a predictive model of metal bioaccessibility. 
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1 INTRODUCTION 
Risk assessors use gastrointestinal (GI) models for the calculation of in vitro bioaccessibility 
(IVBA) to estimate the percentage of ingested arsenic (As), mercury (Hg), and other 
contaminants likely to be solubilized into GI fluids. In contrast to bioaccessibility, oral 
bioavailability, which is calculated using animal testing, refers to the percentage of an ingested 
contaminant that is absorbed across the GI epithelium and reaches systemic circulation. Since 
dissolution into GI fluids is a requisite precursor for absorption, bioaccessibility is often a 
conservative predictor of oral bioavailability. Thus, incorporating bioaccessibility and 
bioavailability into exposure assessments enables risk assessors to account for limitations on the 
release and subsequent absorption of As and Hg after the ingestion of contaminated soils or 
foods. However, numerous data gaps have impeded regulators attempts to incorporate IVBA into 
risk assessment for more than a case-by-case basis. One such data-gap is whether or not it is 
necessary to include a microbially-active colon stage for evaluations of metal bioaccessibility. A 
second data-gap that has impeded the widespread use of bioaccessibility in risk assessment is the 
lack of knowledge pertaining to the factors that determine bioaccessibility of metals other than 
As and lead (Pb). The PhD thesis research described herein addresses both of these data gaps. 
1.1 Objectives and Hypotheses 
The global hypothesis of my PhD research is that the default assumption of 100% 
contaminant bioaccessibility overestimates human exposure to As from contaminated soils and 
to Hg from northern country foods. During the investigation of this global hypothesis, four sub-
hypotheses are evaluated: (1) bioaccessibility of contaminants is dependent upon concentration 
due to kinetic limitations on dissolution, (2) GI microbes in the ileum and colon alter 
contaminant bioaccessibility and/or speciation, (3) the GI microbial effect on bioaccessibility is 
 
 toxicologically relevant, (4) metal bioaccessibility can be predicted according to dissolution 
kinetics. 
For the first sub-hypothesis, the relationship between Hg IVBA vs. concentration is plotted 
for northern country foods and the relationship between As IVBA vs. concentration is plotted for 
contaminated soils. For the second sub-hypothesis, the effect of GI microbes on Hg and As 
IVBA was evaluated for both northern country foods and contaminated soils. The results for this 
research are presented in Chapter 3 (Bioaccessibility of Mercury from Traditional Northern 
Country Foods Measured Using an In Vitro Gastrointestinal Model is Independent of Mercury 
Concentration) and Chapter 4 (Gastrointestinal Microbes Increase Arsenic Bioaccessibility of 
Ingested Mine Tailings Using the SHIME). The mechanism by which total concentration limits 
IVBA is discussed in Chapter 5 (The Effect of Residence Time and LS Ratio on In Vitro Arsenic 
Bioaccessibility from Poorly Crystalline Scorodite). For the third sub-hypothesis, in vitro and in 
vivo research is presented in Chapter 6 (Increased Arsenic Bioaccessibility Due to Microbial 
Activity Does Not Affect Arsenic Bioavailability) to determine whether increased 
bioaccessibility is likely to result in increased bioavailability. The fourth sub-hypothesis is 
evaluated in Chapter 7 (Predicting Metal Bioaccessibility According to Lability via Water 
Exchange Rate Constants).  
Some degree of redundancy in the presentation of this PhD thesis was unavoidable since each 
research chapter was written as an independent manuscript for publication in peer-reviewed 
journals. At the time of submission of this PhD thesis, Chapters 3, 4, and 5 were previously 
published in the academic journals Science of the Total Environment, Environmental Science 
and Technology, and Journal of Environmental Science and Health: Part A 
17 
  
 
Figure 1.1 Chapter overview of BD Laird’s Ph.D. thesis “Evaluating Metal Bioaccessibility 
of Soils and Foods using the Simulator of the Human Intestinal Microbial Ecosystem”.
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 2 LITERATURE REVIEW 
2.1 Human Health Risk Assessment 
Human health risk assessments (HHRA) are performed according to standardized guidelines 
(Health Canada 1994, 2004a) designed to ensure that consistent approaches are adopted in the 
remediation and creation of public policy regarding environmental contamination in Canada. 
These Health Canada guidelines encourage the use of a tiered framework to maximize the 
efficiency of HHRA so that the attention of regulators is not monopolized by substances for 
which negligible risks exist. Early stages of tiered HHRA, also known as Preliminary 
Quantitative Risk Assessment or PQRA), require ultra-conservative assumptions to account for a 
lack of knowledge pertaining to the toxicity and exposure at a contaminated site. If the PQRA 
indicates that the environmental contamination doesn’t present human health risks even with the 
most conservative of assumptions, than it is unlikely that interventions or intensive remediation 
will be required. However, if the PQRA indicates that the site may present health risk then 
further work is necessary to replace the ultra-conservative assumptions with realistic data. This 
research-intensive stage in tiered risk assessment is known as Site Specific Risk Assessment or 
SSRA. Both PQRA and SSRA are similar in that they characterize the effects (i.e., toxicity) and 
exposure (e.g., magnitude and probability) and define health risk according to the overlap of 
these point estimates or distributions (Figure 2.1). 
19 
  
Figure 2.1 Venn diagram illustrating human health risk as a function of the exposure and 
toxicity of a chemical stressor at a contaminated site. 
2.2 Effects Characterizations of Arsenic and Mercury 
Comprehensive reviews of the human health hazards posed by arsenic (ATSDR 2007; IPCS 
2001; Ratnaike 2003) and mercury (ATSDR 1999; Clarkson 2006; IPCS 1976; NRC 2000) are 
presented elsewhere. The purpose of this chapter is not to thoroughly survey decades of research 
investigating the toxicodynamics (i.e., mechanism(s) of action) and health effects of arsenic and 
mercury. Instead, the most critical aspects of arsenic and mercury toxicity (e.g., sensitive organs 
systems, effect measures, and the role of speciation) are introduced, thus providing the 
toxicological context for the exposure analysis described in subsequent research chapters. 
2.2.1 Arsenic health effects 
Arsenic is acutely toxic to humans and lab animals, with a LD50 as low as 4 mg kg-1 following 
a single intraperitoneal injection of sodium arsenite (IPCS 2001; Ratnaike 2003). However, a 
large variation in toxicity is observed between chemical forms of arsenic (ATSDR 2007). For 
20 
 example, the juvenile mouse LD50 for sodium arsenate is 21 mg kg-1 but is 8 mg kg-1 for sodium 
arsenite. An even larger variation in acute toxicity is observed when comparing organoarsenicals 
to inorganic arsenic species. For example, the Lowest Observed Adverse Effects Level or 
LOAEL causing death for Sprague-Dawley rats exposed to monomethylarsonic acid (MMAV) 
ranged between 2449 and 3184 mg kg-1day-1 (IPCS 2001). Furthermore, the organoarsenicals 
arsenobetaine and arsenocholine, which are naturally present in fish and shellfish, are thought to 
be essentially non-toxic (ATSDR 2007). Both MMAV and its dimethylated counterpart 
dimethylarsinic acid (DMAV) also demonstrate rapid excretion with little further metabolism and 
low acute toxicity (ATSDR 2007; Cohen 2006), thereby resulting in the misconception that all 
organoarsenicals are generally non-toxic. In fact, MMAV causes gastrointestinal (GI) effects 
(e.g., diarrhea, tissue damage) at concentrations as low as 1.8 mg As kg-1 day-1 whereas DMAV 
causes bladder and kidney cytotoxicity at concentrations as low as 1.7 mg As kg-1 day (ATSDR 
2007). In addition to these very sensitive endpoints, MMAV exposure in laboratory animals 
results in reproductive (e.g., decreased pregnancy rate and male fertility) and teratogenic effects 
(e.g., decreased fetal growth and minor skeletal defects) (ATSDR 2007; IPCS 2001). 
Additionally, DMAV exposure results in thyroid hypertrophy and GI effects in laboratory 
animals. Rats further metabolize ingested DMAV to trimethylarsine oxide (TMAO) resulting in 
the formation of DMAIII as a reactive intermediate (Cohen 2006). This metabolism of ingested 
DMA, which is unique to rats, is believed to be responsible for the carcinogenicity (neoplastic 
bladder tumors) of DMAV to rats (ATSDR 2007). DMAV has also been shown to act as a tumor 
promoter, increasing the incidence of bladder, kidney, liver, and thyroid cancers to rats co-
administered DNA-reactive carcinogens (Cohen 2006).  
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 In addition to these effects, long-term arsenic exposure can result in a multitude of serious 
adverse effects, from cardiovascular to carcinogenic (Ratnaike 2003). Initial clinical diagnosis of 
chronic arsenic exposure is often based upon dermatological effects, including 
hyperpigmentation (dark brown spots on skin) and hyperkeratosis (either uniform thickening or 
distinct nodules) (Ratnaike 2003). Occupational arsenic exposure has been linked with increased 
rates of cardiovascular disease (Ratnaike 2003), likely due to increased rates of hypertension. 
Neurological effects, including memory loss, behavior changes, and confusion, have been 
observed following arsenic exposure. Evidence for causality for neurological toxicity is 
strengthen by a case-study where the mental function of two adversely affected workers returned 
to normal after withdrawal from arsenic exposure (Ratnaike 2003). Arsenic is a known human 
carcinogen (ATSDR 2007; IPCS 2001), resulting in malignancies in virtually all organs of the 
body (Ratnaike 2003). Interspecies variation in the metabolism, distribution, and excretion of 
arsenic has, however, prevented laboratory animal experiments from modeling the carcinogenic 
effects of arsenic observed in humans (Cohen 2006). Numerous epidemiological studies 
investigating drinking water contamination in Bangladesh, India, and Taiwan have shown that 
inorganic arsenic oral exposure can result in malignancies of the skin, lung, kidney, bladder, 
bone, liver, larynx, lymphatic system, and colon (Guo 2004; Ratnaike 2003; Tchounwou 2004; 
Tsuda 1992). However, it is notable that early epidemiological studies of exposed populations in 
the United States did not demonstrate a strong correlation between arsenic exposure and skin 
cancer risk. It is unknown at this time whether this is a function of limited exposed population 
sizes or upon an increased sensitivity of south Asian populations due to nutritional differences 
and/or deficiencies (ATSDR 2007; Ratnaike 2003).  
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 2.2.2 Mercury health effects 
As observed for arsenic, there are considerable differences in the oral toxicity of mercury 
between chemical species. For example, one may ingest several grams of elemental mercury 
without appreciable adverse effects, while a lethal dose of inorganic mercury can be as low as 50 
mg kg-1, whereas the lethal dose of methylmercury can be as low as 16 mg kg-1 (ATSDR 1999). 
However, it is inaccurate to assert that methylmercury is more toxic than inorganic mercury 
since, before a toxic effect is observed, methylmercury is first intracellularly converted to 
inorganic mercury.  It is the high bioavailability of methylmercury (i.e., the percent absorbed 
across the GI tract epithelium into systemic circulation) that results in methylmercury’s higher 
hazard relative to inorganic mercury (Clarkson 2007). 
Effects upon the central nervous system and kidneys most commonly drive the HHRA of 
mercury (ATSDR 1999; Clarkson 2007).  However, oral exposure to mercury may also result in 
serious GI effects.  GI symptoms of acute mercury exposure include gastric epithelial 
inflammation, ulceration, and necrosis coupled with nausea, vomiting, abdominal cramps, and 
diarrhea (ATSDR 1999).  If exposure is prolonged, inflammation of the distal intestine may 
occur in addition to the formation of forestomach squamous cell papillomas (ATSDR 1999). The 
International Agency for Research on Cancer (IARC) lists methylmercury as a possible human 
carcinogen based upon a small number of epidemiological studies that demonstrated a 
correlation between methylmercury exposure and acute leukemia. Additionally, laboratory 
animal experiments indicate that chronic exposure to methylmercury can result in the formation 
of kidney tumors (NRC 2000). In addition to these tumorigenic effects, mercury exposure 
potentially affects the immune system via lymphocyte proliferation; however, once again the 
effect is dependent upon the mercury chemical species (NRC 2000). 
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 2.3 Exposure Characterization 
2.3.1 Exposure pathways 
Human exposure to environmental contaminants can occur through several pathways: dietary 
consumption of contaminated foodstuffs, consumption of contaminated drinking water, 
inhalation of contaminated particles, and the accidental ingestion of contaminated particles 
(Health Canada 2004a; Paustenbach 2002). The consumption of contaminated foodstuffs and 
drinking water are generally the most important routes of exposure for environmental 
contaminants, with numerous case studies demonstrating the human cost of pollution. For 
example, the contamination of deep-water wells in Taiwan, Bangladesh, and India is associated 
with increased cancer rates and cardiovascular effects, thereby affecting millions of lives 
(Ratnaike 2003). Mass poisonings due to dietary mercury exposure occurred in Minamata, Japan 
in the 1950s and in Iraq in the early 1970s. Although the mercury source varied between these 
case studies, both incidents resulted in numerous developmental and neurological effects in 
exposed individuals (IPCS 1976). These adverse effects included sensory impairment, seizures, 
cerebral palsy, and permanent mental retardation of children exposed during childhood or in 
utero (NRC 2000). 
For sites possessing contaminated soil, the incidental ingestion of soil is often the primary 
route of exposure. For example, in a HHRA of dioxin contaminated soil, 95% of exposure was 
via the ingestion of soil with approximately 78% of an individual’s lifetime exposure occurring 
prior to the age of 5 (Paustenbach 1989). Consequentially, human health risks predicted to occur 
due to the ingestion of contaminated soil drive the remediation strategies of hazardous waste 
sites in the United States (Paustenbach 2002). Health risks due to the incidental ingestion of soil 
are thought to be greatest for children due in-part to the prevalence of hand-to-mouth behavior 
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 by toddlers, resulting in soil ingestion rates between 2 and 10-fold greater than those observed in 
adults (Health Canada 2004a; NCEA 1997; Paustenbach 1989, 2002). 
2.3.2 Quantifying ingestion exposure 
Exposure to ingested contaminants is quantified for dietary consumption of foodstuffs (2.1), 
drinking water consumption (2.2), and the accidental ingestion of contaminated soils and soil-
like particles (2.3) (Health Canada 2004a): 
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Where CS (mg kg-1) represents the contaminant concentration in ingested soil, CW (mg L-1) 
represents the contaminant concentration drinking water, and CFood (mg kg-1) represents the 
contaminant concentration in food items. Similarly, IRS (kg d-1), IRW (L d-1), and IRFood (kg d-1) 
represent the receptor (e.g., infant, toddler, teenager, or adult) intake rates for ingested soil, 
drinking water, and food items, respectively. Both the AFGIT and RAFGIT (unitless) refer to the 
relative bioavailability (RBA) of the ingested contaminant, which reflects the percent of a 
contaminant that is absorbed into systemic circulation relative to that of a reference dose. D1, D2, 
and D3 are exposure duration modifiers representing the fraction of days per year and number of 
years per lifetime to which the receptor is exposed to the contaminant. Body weight (BW) 
represents the body weight of the receptor and LE represents the life expectancy of the receptor. 
Notably, the number of years to which people are exposed to the contaminant and the LE of the 
receptor are only included in the exposure estimates for carcinogens (Health Canada 2004a). 
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 2.3.3 Estimating gastrointestinal absorption  
Risk assessors performing PQRA in Canada are typically required to assume that 100% of an 
ingested contaminant is absorbed into systemic circulation (i.e., AFGIT = 1.0) (Health Canada 
2004a). However, if the PQRA indicates that a higher-tier (i.e., more realistic albeit less 
protective) SSRA is necessary, then limitations on GI absorption may be accounted for by setting 
the AFGIT to a value less than 1.0 (US EPA Region 8 2005). The relative bioavailability (RBA) 
of ingested contaminants following oral exposure is traditionally calculated using in vivo animal 
experiments that monitor the percent of an ingested dose to be absorbed into the animals’ 
bloodstream (Diamond 1998). The RBA can be calculated using any one of a number of model 
organisms; however, bioavailability researchers have of late emphasized the importance of 
selecting test organisms (e.g., cynomolgus monkeys, juvenile swine) that possess GI tracts 
similar to humans (Roberts 2006). Additionally, the approach used to estimate contaminant RBA 
varies with the toxicokinetics of the contaminant of concern (Diamond 1998). For example, 
arsenic RBA is measured using arsenic urinary excretion since the majority of an ingested 
arsenic dose is metabolized and then excreted in urine within several days (Casteel 2001; 
Rodriguez 1999). In contrast, mercury is slowly eliminated via the bile duct, thereby under going 
enterohepatic circulation prior to fecal excretion (ATSDR 1999). Consequentially, researchers 
have utilized gamma-emitting Hg isotopes to evaluate the retention and bioavailability of 
ingested Hg (Nielsen 1992). A similar body-retention approach is used for PAHs and other 
lipophilic contaminants (Budinsky 2008); however, blood, liver, and/or adipose tissue 
concentrations are typically employed rather than radio-labeling. Regardless of the approach 
used to estimate contaminant oral bioavailability (e.g., urinary excretion, radio-labeled isotopes, 
or blood concentrations), the exorbitant time and financial investments required make such tests 
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 inefficient for SSRAs. For example, researchers may spend up to 4 weeks and $10,000, requiring 
the euthanasia of at least 12 animals, to calculate the RBA of As from a single soil sample. 
Since the costs of such in vivo animal experiments are often prohibitively expensive, not to 
mention ethically troubling, researchers have long sought in vitro alternatives for calculating 
AFGIT (Ruby 1999). The Physiologically Based Extraction Test (PBET), an in vitro 
gastrointestinal (GI) model that simulates the physical, chemical, and enzymatic conditions of 
the human GI tract, was first developed for the calculation of lead bioaccessibility from 
contaminated soils (Ruby 1993). Contaminant bioaccessibility, in contrast to bioavailability, 
refers to the fraction/percent of an ingested contaminant that is released into simulated GI fluids 
(Rodriguez 1999). Since contaminant dissolution is typically required prior to the absorption of 
the contaminant across the GI epithelium, bioaccessibility is considered to be a conservative 
predictor and in vitro surrogate for in vivo bioavailability (Oomen 2003). Numerous other in 
vitro GI models (e.g., Simple Bioaccessibility Extraction Test or SBET; Ohio-State In Vitro 
Gastrointestinal Tract or OSU-IVG; Simulator of the Human Intestinal Microbial Ecosystem or 
SHIME; Unified BARGE Model or UBM, among others) have since been developed and refined 
for the calculation of metals and metalloids (e.g., arsenic, mercury, chromium, copper, zinc, 
nickel, uranium) and organic contaminants (e.g., PAHs and PCBs) (Denys 2008; Fendorf 2004; 
Frelon 2007; Hack 1996; Meunier 2010; Rasmussen 2008; Rodriguez 1999; Van de Wiele 2004; 
Welfringer 2009). 
2.3.4 Validating in vitro bioaccessibility 
Before measures of in vitro bioaccessibility may be accepted for SSRA, the in vitro GI model 
must be validated and proven to reflect bioavailability data collected using one of the standard in 
vivo techniques described above (Basta 2007; Rodriguez 1999; US EPA Region 8 2005). 
Extensive work is underway to validate in vitro GI models for the measurement of lead, arsenic, 
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 and more recently cadmium and antimony in contaminated soils (Basta 2007; Caboche 2009; 
Casteel 2001; Roberts 2006; Rodriguez 1999; Schroder 2004). No such validation procedures 
have yet been performed for contaminated foodstuffs. To perform these validation studies, the 
soil contaminant concentration is measured in numerous test materials from a contaminated site. 
Subsequently, the contaminant percent bioaccessibility under simulated gastric and/or intestinal 
conditions are quantified using an in vitro GI model. Thereafter, the RBA of the contaminant is 
measured using an in vivo animal model. Finally, the correlation between percent bioaccessibility 
and contaminant RBA is assessed and the model declared valid according to the model fit, and 
occasionally slope, of the regression equation (US EPA Region 8 2005). 
This approach to GI model validation is, however, not without its limitations. For example, in 
vivo bioavailability trials are typically performed for test materials with high contaminant 
concentrations (e.g., >500 mg kg-1 As) due to detectability constraints. For example, the 
measurement of the RBA of As (Casteel 2001) in a moderately contaminated soil (e.g., 250 mg 
As kg soil-1) requires each animal in the highest dosing group to ingest 10 g of soil per day. Such 
large soil ingestion rates are impractical due to difficulties ensuring complete dose ingestion. In 
contrast, IVBA is most useful for soils containing lower contaminant concentrations as these are 
the soils for which bioaccessibility is most likely to effect decision making. For example, an 
arsenic contaminated soil containing a concentration 2000 mg kg-1 greater than background 
would require a bioavailability of 0.6% to be equivalent to the CCME SQG of 12 mg kg-1 (i.e., 
[12 mg kg-1/2000 mg kg-1] x100% = 0.6%). However, neither in vitro nor in vivo techniques 
offer sufficient precision to confidently and reliability predict bioaccessibilities or 
bioavailabilities below 1%. Therefore, remediation options (e.g., excavation, phytoremediation, 
etc) are almost certain to proceed for such highly contaminated sites regardless of bioavailability. 
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 Consequentially, current procedures validating the use of in vitro GI models may be predicated 
on the assumption that the correlation between bioaccessibility and bioavailability is dose 
independent. In addition, current validation procedures suggest in vitro bioaccessibility under 
simulated gastric conditions predicts in vivo bioavailability just as well as under simulated 
intestinal conditions (Juhasz 2008). This observation is contrary to the vast majority of 
physiological knowledge that places the majority of GI uptake in human intestine (Gad 2007).  
2.3.5 Uncertainty and data gaps 
Several data gaps have impeded the widespread utilization of in vitro GI models for HHRA. 
One of these data gaps is whether or not bioaccessibility is relevant to the estimation of mercury 
exposure from foodstuffs. Adult exposure to environmental contaminants such as mercury is 
rarely driven by accidental ingestion of soils (Paustenbach 1989) and may, instead, be of dietary 
origin (BCS 2007). However, the vast majority of bioaccessibility data for metal contaminants 
has focused upon contaminated soils and soil-like materials (Ruby 1996). Consequentially, it is 
as of yet unknown whether contaminant solubilization from ingested foods limits GI absorption 
and, thus, oral exposure to dietary contaminants. 
Despite decades of research evaluating the use of in vitro GI models for measuring soil 
contaminant bioaccessibility, a number of data gaps persist (Ruby 1993). For example, in vitro 
bioaccessibility is occasionally dependent upon concentration (Beak 2006b); however, the 
factors that result in this relationship being only occasionally observed are largely unknown. An 
inverse relationship between bioaccessibility and concentration is of particular concern since this 
may result in the underestimation of bioaccessibility if not also observed in vivo. For example, 
the Liquid to Soil ratio (LSR), representing the volume of simulated GI fluid per gram of soil, of 
in vitro models is typically far lower than observed in vivo (Richardson 2006). Consequentially, 
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 solubility limits may be reached in GI models, thereby artificially restraining contaminant 
dissolution and in vitro bioaccessibility.  
Another data gap impeding the widespread application of in vitro GI models is whether it is 
necessary to measure bioaccessibility under simulated gastric conditions only or if simulated 
intestinal conditions must also be included. Although the majority of in vitro GI models 
published in peer-reviewed literature include an intestinal phase (Van de Wiele 2007), validation 
studies indicate that gastric bioaccessibility offers superior correlation with in vivo 
bioavailability results. Additionally, most in vitro GI models that include a simulated intestinal 
stage do not incorporate microbial activity (Van de Wiele 2007) even though microbes are 
known to modify the speciation (Kuroda 2001) and biological activity of ingested contaminants 
(Van de Wiele 2005). However, the relevance of microbial effects upon contaminant 
bioaccessibility to HHRA has yet to be established. 
It is likely, though, that the largest impediment to the widespread use of in vitro 
bioaccessibility is that the development of GI models has largely proceeded on an ad hoc basis. 
Consequentially, the majority of bioaccessibility results obtained to date focus upon arsenic, and 
to a lesser extent lead, with far less information available for other metals and organic 
contaminants. Although numerous articles have assessed the role of soil properties (Juhasz 2007; 
Roberts 2006; Yang 2002; Yang 2005), constituents (Wragg 2007a), and mineralogy (Meunier 
2010; US EPA Region 8 2005) on soil contaminant bioaccessibility, these studies have focused 
exclusively on arsenic bioaccessibility. Therefore, it remains unknown whether the soil 
properties that determine arsenic bioaccessibility (e.g., pH, Fetotal, FeSO4, clay, fine-grained 
silicate, etc) also influence the bioaccessibility of other metal contaminants. As such, utilizing 
multi-metal approaches to identify fundamental metal properties controlling metal 
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 bioaccessibility addresses a critical data-gap preventing the widespread use of metal 
bioaccessibility in HHRA.   
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 3 BIOACCESSIBILITY OF MERCURY FROM TRADITIONAL NORTHERN COUNTRY 
FOODS MEASURED USING AN IN VITRO GASTROINTESITNAL MODEL IS 
INDEPENDENT OF MERCURY CONCENTRATION 
3.1 Introduction 
Traditional country foods offer tremendous social, health, and economic benefits to Inuit in 
northern Canada (NCP 2003); however, the presence of environmental contaminants such as 
mercury (Hg) in country foods may also present health risks.  The risk assessment of ingested Hg 
to the Canadian public is calculated under the assumption that 100% of the Hg in fish flesh is in 
the form of methylmercury (MeHg) (BCS 2007).  The hazard of MeHg makes this assumption 
both conservative and protective (BCS 2007).  The assumption that dietary mercury is 100% 
MeHg is realistic for southern Canadians (i.e., those consuming typical western diets of cereals, 
legumes, dairy products, fruits, vegetables, and meat) since fish is their primary source of Hg 
exposure (BCS 2007) and the majority of Hg in fish is MeHg (ATSDR 1999; BCS 2007; 
Wagemann 1997).  Although fish consumption rates of Inuit can be substantially higher relative 
to southern Canadians (BCS 2007), fish consumption constitutes a small proportion of the Inuit 
Hg exposure (NCP 2003). The dietary Hg risk assessment of Inuit could be improved by 
systemically evaluating the concentration, speciation, and bioavailability of Hg from a variety of 
traditional country foods.   
Although both HgII and MeHg are primarily absorbed in the small intestine, toxicokinetic 
differences exist between HgII and MeHg (ATSDR 1999; Clarkson 2007; Nielsen 1992).  For 
example, only a fraction of ingested HgII is absorbed across the gastrointestinal (GI) tract 
(Kamijo 2004; Nielsen 1992).  In contrast, both human and animal studies demonstrated nearly 
complete absorption of Hg when ingested as MeHg contaminated fish, or as MeHg spiked into 
water, oils, or fish muscle homogenates (ATSDR 1999; Clarkson 2007).  The absorption of 
MeHg across the intestinal epithelium is mediated by brush border dipeptide transporters due to 
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 the structural homology of L-cysteine-MeHg complexes and methionine (Clarkson 2007).  In 
contrast, the mechanisms of HgII absorption are not yet completely understood (Hoyle 2005).   
In vitro GI models are useful tools in the measurement of Hg bioaccessibility, i.e., the fraction 
of ingested Hg that is solubilized into GI fluids (Ruby 1999).  In contrast, Hg bioavailability 
refers to the fraction of ingested Hg that is absorbed across the intestinal epithelium into 
systemic circulation (Ruby 1999).  Oral Hg bioavailability may be reduced due to complexation 
with fiber and phytates (ATSDR 1999); therefore, assuming Hg from foods to be completely 
absorbed may overestimate the health risk of consuming traditional country foods.  The 
bioaccessible fraction of Hg, that which is solubilized in the human GI tract, may be a better 
indicator of exposure for use in risk assessment.  This principle, in conjunction with the high cost 
of in vivo oral bioavailability assessments, has led to the development of in vitro GI models for 
the evaluation of contaminant bioaccessibility from soils, slags, and mine tailings (Ruby 1999).  
Similarly, in vitro models were used to predict GI Hg absorption in channel catfish, Ictalurus 
punctatus (Leaner 2002), and humans (Cabanero 2004; Cabanero 2007; Shim 2009).  The 
Simulator of the Human Intestinal Microbial Ecosystem (SHIME) is an in vitro GI model that is 
unique in comparison with other in vitro models because it incorporates the activity of the human 
GI microbiota (De Boever 2000; Van de Wiele 2007). The SHIME mimics the physiological 
conditions (e.g., pH, residence time, enzymes, etc) of the stomach, small intestine, and colon to 
monitor the solubilization of ingested contaminants in the GI tract. Microorganisms (e.g., sulfate 
reducing bacteria) are capable of reducing mercury to form unabsorbable sulfide complexes 
(ATSDR 1999), methylating HgII to form MeHg or demethylating MeHg to form HgII (Craig 
2004).  Antibiotic treatment of rats decreased Hg elimination following oral exposure to 
methylmercuric chloride, indicating that the rat GI microflora metabolized MeHg (Rowland 
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 1980) via the production of elemental mercury and a volatile sulfur derivative of methylmercury 
(Rowland 1978). Furthermore, the microbial community of the rat jejunum first methylated 
HgCl2, which was subsequently reduced to elemental Hg via microbial metabolism (Ludwicki 
1990). However, the methylation of ingested inorganic Hg following human oral exposure has 
yet to be conclusively demonstrated in vivo (Barregard 1994).        
Metal(loid) concentration of ingested matrices sometimes limits bioaccessibility and 
bioavailability due to constraints upon contaminant dissolution and/or absorption.  Although 
MeHg bioavailability was independent of MeHg concentration in an in vivo mouse model 
(Nielsen 1992), it is unknown if this is also true for in vitro bioaccessibility. The objective of this 
research is to assess the relationship between Hg bioaccessibility and concentration in country 
foods.  In addition, we will evaluate for the presence of Hg biotransformation (e.g., Hg species 
demethylation or methylation) from several country foods.  As such, we hypothesize that Hg 
bioaccessibility is inversely related to the Hg concentration in the food and that GI 
microorganisms alter the speciation of the ingested Hg via methylation or demethylation of Hg 
species in the GI lumen.  The evaluation of these hypotheses are limited by the fact that the 
SHIME, like other in vitro GI models, are not yet validated for the measurement of Hg 
bioaccessibility relative to in vivo data. 
3.2 Materials and Methods 
3.2.1 Inuit food samples 
Food samples collected between 1998 and 2006 (n=16), were acquired from sample archives 
maintained by Dr Hing Man Chan (University of Northern British Columbia, Canada) and Dr 
Derek Muir (Environment Canada, Burlington, Ontario, Canada) as part of their on-going 
monitoring studies. The food samples, which were stored at -20°C, included the kidney and 
tongue of caribou (Rangifer tarandus L.), the intestine of bearded seal (Erignathus barbartus E.), 
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 the blood, brain, and liver of ringed seal (Phoca hispida S.), the flesh of walrus (Odobenus 
rosmarus L.), the skin of narwhal (Monodon monoceros L.) and beluga (Delphinapterus leucas 
P.), and the flesh of Arctic char (Salvelinus alpinus L.). The majority of the foods (14 of 16) 
were uncooked; however the bearded seal intestine was boiled and one of two walrus flesh 
samples were aged. The total Hg (HgT) concentration (i.e., [HgT]) in the various foods ranged 
between 0.01 mg kg-1 and 3 mg kg-1 (wet weight). 
 
3.2.2 Dynamic Simulator of the Human Intestinal Microbial Ecosystem 
A three compartment dynamic SHIME model, constructed at the University of Saskatchewan 
(Saskatoon, Saskatchewan, Canada) according to previously published specifications (De Boever 
2000; Laird 2007), maintained a microbial community representative of that found in the distal 
human intestine. The SHIME is operated under anaerobic conditions with human GI 
microorganisms in the colon stage since GI microbes may influence Hg bioaccessibility and 
speciation. In brief, a feces: thioglycolate buffer mixture was centrifuged and the supernatant 
was added to a carbohydrate-based nutrition solution (previously autoclaved) in a double-
jacketed reactor flask. The carbohydrate nutrition solution contained 5.01 g KHCO3 (MP 
Biomedicals), 2.92 g NaCl (EMD), 0.5 g arabinogalactan (Fluka), 1.0 g pectin (ICN 
Biomedicals), 0.5 g xylan (Sigma), 2.1 g potato starch (EMD), 0.2 g glucose (EMD), 1.5 g yeast 
extract (BD BactoTM), 0.5 g peptone (BD BactoTM), 2.0 g mucin (Sigma), 0.25 g L-cysteine (EM 
Science) per liter of Milli-Q™ water. The L-cysteine concentration in the dynamic SHIME colon 
suspension is equivalent to the maximum dietary cysteine used in a recent publication 
investigating the role of dietary cysteine in the synthesis of erythrocyte glutathione (Courtney-
Martin 2008). Nutrition solution (100 mL) was acidified to pH 2 via the addition 12 M HCl 
(EMD OmniTraceTM) and was added to the stomach every 8 hours. Following a 2 hour residence 
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 time in the stomach, the nutrition solution was pumped into the small intestine and mixed with 
small intestinal solution (50 mL) containing 12.5 g L-1 NaHCO3 (EMD), 6.0 g L-1 Oxgall (BD 
DifcoTM), 0.9 g L-1 pancreatin (Sigma). Following two hours in the small intestine, the 
nutrition/small intestine mixture was pumped into the colon stage containing the large intestinal 
microbial community. The SHIME, maintained at 37°C under nitrogen atmosphere, containing 
108 total aerobes CFU mL-1 and 108 total anaerobes CFU mL-1, included Fecal Coliforms, 
Clostridia, Enterococci, Staphylococci, Bifidobacteria, and Fungi. Aliquots of the colon 
microbial cultured in the dynamic SHIME were used for static batch colon digests of country 
foods. 
3.2.3 Static Simulator of the Human Intestinal Microbial Ecosystem 
Mercury bioaccessibility from country foods was measured from the stomach, small intestine, 
and colon stage of the SHIME using a static batch design (Laird 2007) making sample digestion 
order irrelevant to the calculation of HgT bioaccessibility. In brief, 0.2 g of country food was 
added to 50 mL polypropylene conical centrifuge tubes and then 8 mL of pH 1.5 diluted HCl 
(EMD OmniTraceTM) was added. The pH of the food/gastric solution was corrected to 1.5 ± 0.1 
and 6.8 µL of concentrated porcine pepsin (Calbiochem) was added to the mixture to facilitate 
protein digestion. The country food stomach digests were horizontally shaken at 70 rpm in an 
incubator shaker heated to 37°C for 2 hours. Following the stomach residence time, 4 mL of 
small intestinal solution (as described above) was added to the centrifuge tube. Sample pH was 
corrected to 6.5 ± 0.1 and the headspace was replaced with a nitrogen atmosphere using an 
anaerobic glove box.  Subsequently, the small intestine digests were returned to the incubator 
shaker and incubated with shaking for an additional 2 hours. Following the small intestinal 
residence time, 8 mL of colon SHIME solution from the dynamic SHIME colon was added to the 
intestinal country food digests. The pH was corrected to 6.3 ± 0.1 and the headspace was 
36 
 replaced with a nitrogen atmosphere, as previously described. Subsequently, the colon digests 
were returned to the incubator shaker and incubated with shaking for an additional 18 hours. 
Additionally, the colon SHIME digests of the country foods were repeated using previously 
sterilized (i.e., autoclaved) and cooled dynamic SHIME colon suspension. 
  The separation of bioaccessible contaminants from in vitro GI fluids often uses 
centrifugation, microfiltration (0.45 µm) or ultrafiltration for the assessment of contaminant 
bioaccessibility. It is not clear what method best estimates Hg bioaccessibility; however, 
ultrafiltration may be most appropriate because it represents the size fraction thought to cross the 
intestinal lumen (Van de Wiele 2007). Following the stomach, small intestinal, and colon stages, 
the SHIME fluid/country food mixtures were first syringe filtered (Whatman 0.45 µm, Glass 
Micro-Fiber) and then 3.5 mL of the filtered solution was passed through the 10 kDa membrane 
of an ultrafiltration centrifuge cartridge (Pall, Microsep, 10 kDa).  The 10 kDa filtrate was 
transferred from the ultrafiltration centrifuge cartridge, preserved in 5% HCl (EMD 
OmniTraceTM), and frozen prior to transportation to Quicksilver Scientific (Denver, CO, USA) 
for chemical analysis. 
Mercury in the 10 kDa filtrate was defined as bioaccessible and percent HgT bioaccessibility 
was calculated according to: 
( ) ( ) %100×××=  MassFood  [HgT]Volume Fluid  [HgT] bility Bioaccessi HgT foodfiltrate  (Eqn 3.1) 
Where [HgT]filtrate is the total Hg concentration (µg mL-1) in the 10 kDa filtrate, Fluid Volume 
is the total volume of the GI fluid  (mL), [HgT]food is the total Hg concentration in the food item 
(µg g-1), and Food Mass is the total mass (g) of the food digested through the SHIME.  Since the 
concentration of MeHg and HgII in the undigested country foods was not evaluated, the IVBA of 
MeHg and IVBA of HgII cannot be calculated.  Instead, the bioaccessible MeHg concentration of 
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 the country foods (i.e., [MeHg]10 kDa,Food) was calculated to evaluate the role of GI microbes of 
the speciation of bioaccessible Hg: 
( )  MassFoodVolume Fluid  [MeHg]  MeHg filtrateFood 10kDa, ×=][  (Eqn 3.2) 
Where [MeHg]filtrate is the MeHg concentration (µg mL-1) in the 10 kDa filtrate, Fluid Volume 
is the total volume of the gastrointestinal fluid (mL), and Food Mass is the total mass (g) of the 
food digested through the SHIME. [MeHg]filtrate was adjusted for background MeHg in the 
SHIME digest (see Chemical Analysis); however, the calculation of [MeHg]filtrate assumes 
negligible loss (e.g. adsorption) of MeHg in the ultrafiltration cartridge. This assumption has yet 
to be verified. The GI microbial effect size on HgT bioaccessibility, [MeHg]10 kDa,Food, and the 
proportion of bioaccessible HgT as MeHg was calculated according to: 
( ) )( %100×−= SterileSterileActive    SizeEffect   (Eqn 3.3) 
Where Active denotes the HgT bioaccessibility, [MeHg]10 kDa,Food, or proportion of 
bioaccessible HgT as MeHg in the presence of GI microbial activity.  Sterile denotes the HgT 
bioaccessibility, [MeHg]10 kDa,Food, or proportion of bioaccessible HgT as MeHg, without GI 
microbial activity.  The calculation of Effect Size (Equation 3.3) assumes that the microbial 
activity is the dominant source of bacterial metabolism in the SHIME and was not affected by 
microorganisms originally present within the country foods. The presence of cysteine and 
thioglycolate in the SHIME colon suspension may have facilitated the release of Hg from the 
foods into solution. However, the calculation of the microbial effect size controls for this factor 
since the active and sterile SHIME colon contained the same concentrations of cysteine and 
thioglycolate. 
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 3.2.4 Chemical analysis 
Determination of total [HgT]food in the majority of the food samples was accomplished 
through the use of a Hg analyzer (MA-2000, Nippon Instruments Corporation) that uses sample 
combustion to, gold amalgamation, and Hg detection by atomic absorption spectrometry (C-GA-
AAS). Approximately 5-10 mg of food samples were used in each measurement from three 
subsamples of each food. The sample was placed in ceramic boats containing additives (1:1 
calcium hydroxide: sodium carbonate and activated alumina). The purpose of the additive is to 
absorb substances such as sulfates or halogens that could potentially be released during sample 
combustion, which could interfere with the absorbance measurement. The samples were 
combusted at 850°C. The Hg vapor that is released is trapped by gold-coated diatomite particles 
and is subsequently released into an absorption cell.  The Hg concentration is then determined 
using atomic absorption spectrometry at a wavelength of 253.7 nm.  The detection limit for the 
analysis of HgT content of the foods was 1 ng g-1. The ensure accuracy, blanks and standard 
reference material check were run periodically. Blanks, which are ceramic boats containing only 
additive, gave values below the detection limit. Moreover the standard reference materials 
Dogfish Muscle Certified Reference Material for Trace Metals DORM-2 (NRC, Ottawa) 
consistently gave recoveries above 85%. The mean (n=3) of the HgT was calculated and the 
coefficient of variation for the HgT concentrations was consistently less than 10%. 
The [HgT]food of the Arctic char was measured in triplicate at the National Laboratory for 
Environmental Testing at the Canada Centre for Inland Waters, as previously described (Gantner 
2009).  In brief, Arctic char flesh was acid-digested in a closed-vessel high-pressure microwave 
oven and total Hg was measured using cold-vapor atomic absorption spectrophotometry. 
Average Hg recovery, measured from certified reference materials (DOLT-2, DORM-2, TORT-
2; National Research Council of Canada, Ottawa, ON) for each batch of 20 samples, was 129%. 
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 [HgT]food of the Arctic char samples were only accepted when the coefficient of variation of the 
mean of the triplicate samples was less than 10%. 
The [HgII] and [MeHg] in the 10 kDa filtrate (5 mL) were measured using Hg-Thiourea 
complex Liquid Chromatography – Cold Vapour Atomic Fluoresence Spectrometry (HgTu/LC-
CVAFS) according to a previously published technique utilizing the complexation affinity of 
thiourea with Hg (Shade 2008). In brief, a thiourea (TU) and hydrochloric acid leaching solution 
was added to each of the acid-preserved 10 kDa filtrate samples, forming hydrophilic cationic 
Hg(Tu)22+and CH3HgTu+ complexes with both HgII and MeHg. This step released any Hg 
species potentially bound to the polypropylene container walls. To evaluate the efficacy of TU in 
mobilizing Hg from the polypropylene tubes we performed a TU leaching test on the extracted 
tubes. This TU leaching test indicated that the average Hg recovery was 89.6% (n=4). The 
samples were then transferred to acid-cleaned borosilicate glass vials and potassium iodide added 
to create neutral CH3HgI and HgI2 complexes that were then pre-concentrated on a 
polydivinylbenzene (I-PDVB). Excess iodide was then washed from the column prior to elution 
with acidic thiourea and sequential on-line separation by ion-pairing reversed-phase liquid 
chromatography, cold vapor generation, gas-liquid separation, and detection of formed Hg0 by 
atomic fluorescence. The absolute detection limits of the analysis are 0.4 pg for MeHg and 0.7 
pg for HgII (Shade 2008), relative detection limits depend on the amount of sample prepared and 
the volume of the prepared solution pre-concentrated.  Certified Reference Material (BCR-463, 
DOLT-3, Mussel SRM 2796) recovery ranged between 95 and 106% for MeHg (n=5) and 98 and 
105% for HgII(n=5).  Matrix spike recovery ranged between 92 and 98% for MeHg and 92 and 
101% of HgII and the average percent deviation of MeHg and HgII was 9% and 14%, 
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 respectively.   The mean (n=6) procedural SHIME blanks concentration was 1.5x10-4 ng mL-1 
MeHg and 6.5x10-3 ng mL-1 HgII. 
3.2.5 Statistical analysis 
Fisher-Protected Least Significant Difference (LSD) (α=0.05, n=15) tested the hypothesis that 
the concentration of bioaccessible (i.e., that which passes the 10 kDa filter) MeHg in the colon is 
affected by the activity of GI microorganisms. A lack of replication within different types of 
food necessitated the pooling across food type for the comparison of mean [MeHg]10kDa,Food for 
the two microbial treatments (i.e., active versus sterile colon). Therefore, the mean [MeHg]10 kDa, 
Food of the 15 foods was compared with or without the activity of GI microbes.   
To evaluate if HgT IVBA from foods was inversely related to [HgT]food, ANOVA nonlinear 
regression analysis was performed. A null (i.e., intercept-only) model (HgT ABA ~ a) was 
compared (F-test, α=0.05) to a 2-parameter reciprocal (HgT ABA ~ a – b-c*HgTppm) model where 
HgT ABA is the total Hg bioaccessibility and HgT ppm is the total Hg concentration in the food. 
To evaluate if HgT bioaccessibility of mammal organs differed from fish flesh, small intestinal 
HgT IVBA of foods from mammal organs (terrestrial and marine, n=5) was compared with that 
of fish (i.e., Arctic char, n=6) using a Fisher Protected LSD to test the hypothesis that type of 
food influences (α=0.05) HgT IVBA in the SHIME small intestine. Similarly, the GI microbial 
effect size on [MeHg]10 kDa Food from mammals was compared with that of fish using a Fisher’s 
Protected LSD, thereby testing the hypotheses that type of food influences the GI 
microorganism’s affect upon [MeHg]10 kDa,Food.  The small number of samples limits the 
interpretation of the data to this set of samples; therefore, it would be inappropriate to extrapolate 
the results of this comparison to Inuit country foods in general. 
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 3.3 Results 
Small intestinal HgT IVBA for these 16 country food samples ranged between 1 and 93% and 
was independent of [HgT]food (Table 3.1).  The nonlinear (reciprocal) model of [HgT]food and 
HgT bioaccessibility did not significantly improve the regression when compared to the 
intercept-only model (F= 0.5726, p=0.578).  The CV of small intestinal HgT IVBA was greater 
from duplicated (n=2) digests of Beluga skin than from Arctic char, indicating that future studies 
should digest samples in triplicate to reduce measurement uncertainty. Mean small intestinal 
HgT IVBA, pooled between foods, was 35 % (n = 16, CV = 79%), which is higher than the HgT 
IVBA previously reported from other fish species (Tuna 9%; Sardine 13%; Swordfish 17%) 
(Cabanero 2004; Cabanero 2007). The higher HgT IVBA in this study could be due to 
differences in either sample composition or in vitro model operational parameters.  Since Hg in 
the fish flesh is predominantly MeHg (BCS 2007; Wagemann 1997), Hg ingested via fish 
consumption is thought to be completely absorbed across the GI tract.  In contrast, mean small 
intestinal Arctic char HgT bioaccessibility was 56% (n =6, CV = 38%) in the SHIME and 
Cabanero et al. (2004, 2007) reported fish HgT bioaccessibility below 20%.  Therefore, in vitro 
Hg bioaccessibility may systematically underestimate Hg bioavailability from foods, perhaps due 
to a lack of brush border enzymes and/or Hg absorption mechanisms.  Consequentially, it is 
essential that in vitro Hg bioaccessibility be calibrated (i.e., validated) according to in vivo oral 
bioavailability prior to use in human health risk assessment to ensure the accuracy of Hg 
bioaccessibility data. 
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 Table 3.1 Food total mercury (HgT) concentrations ([HgT]food), small intestinal HgT 
bioaccessibility, and bioaccessible methylmercury (MeHg) concentrations ([MeHg]10 kDa food) 
digested through the Simulator of the Human Intestinal Microbial Ecosystem. Concentrations 
were expressed by a wet weight basis. 
Species 
(Scientific name) 
Food 
Tissue 
[HgT]food  
(mg kg-1) 
% HgT 
Bioaccessibility 
(Std Dev) 
[MeHg]10 kDa,Food
(mg kg-1) 
Caribou 
(R. tarandus) Tongue 0.02 25.0 0.0058 
Walrus 
(O. rosmarus) Flesh 0.07 15.5 0.011 
Ringed seal 
(P.hispida) Blood 0.11 66.1 0.082 
Walrus 
(O. rosmarus) Flesh 0.12 47.7 0.063 
Bearded seal 
(E. barbartus) Intestine 0.14 4.6 0.0068 
Arctic char 
(S. alpinus) Flesh-I 0.15 52.3 (1.6) 0.091 (0.003)  
Ringed seal 
(P. hispida) Brain 0.16 0.7 0.0058 
Caribou 
(R. tarandus) Kidney 0.19 0.7 
< Detection 
Limita
Arctic char 
(S. alpinus) Flesh-II 0.26 41.1 0.12 
Narwhal 
(M. monoceros) Skin 0.34 0.5 0.0022 
Arctic char 
(S. alpinus) Flesh-III 0.34 93.9 0.36 
Beluga 
(D. leucas) Skin 0.37 41.4 (7.8) 0.17 (0.03) 
Ringed seal 
(P. hispida) Liver 0.45 18.9 0.068 
Arctic char 
(S. alpinus) Flesh-IV 1.29 55.5 0.81 
Arctic char 
(S. alpinus) Flesh-V 2.09 33.2 1.51 
Arctic char 
(S. alpinus) Flesh-VI 3.40 60.2 2.32 
a Detection Limit = 0.4 pg 
 
The thioglycolate and L-cysteine in the dynamic SHIME may have encouraged the 
release of Hg into the SHIME fluid due to their complexation affinity for Hg. Since the 
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 thioglycolate and L-cysteine were present in the static SHIME colon but not in the SHIME small 
intestine, comparing the HgT bioaccessibility between these SHIME stages provides indirect 
evidence that the thioglycolate and L-cysteine did not bias the HgT bioaccessibility results. The 
addition of the colon SHIME suspension consistently decreased HgT bioaccessibility in the 
SHIME colon (with thioglycolate; HgT bioaccessibility: 0.2 – 42%) relative to the SHIME small 
intestine (without thioglycolate; HgT bioaccessibility 0.5 – 93%).  These results suggest that the 
presence of thioglycolate and L-cysteine did not increase HgT bioaccessibility from country 
foods in the SHIME. 
3.4 Discussion 
No differences were observed between either [MeHg]10 kDa, Food (F1,28 = 1.75, p=0.197) or 
HgT bioaccessibility (F1,28 = 2.32, P=0.139) of country foods in the presence or absence of GI 
microbial activity. However, our ability to detect differences between the active and sterile colon 
was confounded by pooling differing types of foods. For example, GI microorganism activity 
decreased [MeHg]10 kDa, Food  between 13 and 100% relative to the sterile control from the 
majority (7 out of 8) of uncooked mammalian country foods (Figure 3.1). 
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Figure 3.1 Gastrointestinal microbial effect size on 10 kDa MeHg concentration, total 
mercury (HgT) bioaccessibility, and proportion of bioaccessible mercury (Hg) as methylmercury 
(MeHg) from country foods digested through the Simulator of the Human Intestinal Microbial 
Ecosystem. Of the 10 food types, only Arctic char flesh was replicated (n=6) via pooling results 
from the 6 Arctic char samples. Error bars represent standard error of the mean. 
 
In contrast, GI microbial activity increased [MeHg]10 kDa,Food for uncooked narwhal skin 
(19%), boiled seal intestine (340%), and uncooked Arctic char flesh (n=6, 67 – 760%) (Figure 
3.1). A similar pattern was observed for HgT bioaccessibility, thereby demonstrating a 
correlation between HgT bioaccessibility and [MeHg]10 kDa as HgT concentrations in the GI 
fluids were driven by MeHg. The proportion of bioaccessible HgT as MeHg decreased up to 
100% in the presence of GI microorganisms relative to sterile control samples (Figure 3.1).  The 
decrease in [MeHg]10 kDa,Food from uncooked mammalian foods in the presence of GI microbes 
45 
 may be due to microbial demethylation of MeHg present in the country foods. Alternatively, 
variations in [MeHg]10 kDa,Food and the proportion of bioaccessible HgT as MeHg observed from 
some foods (Figure 3.1) may be due to preferential coordination of MeHg to ligands greater than 
10 kDa (i.e., not bioaccessible) in the active versus sterile colon. However, microbial 
demethylation is the more plausible mechanism explaining decreases in [MeHg]10kDa,Food since 
the matrix composition of the active and sterile colon suspension is likely equivalent. 
Demethylation of ingested MeHg was previously observed in vivo (Seko 2001) and in vitro in 
the presence of Escherichia coli (Oremland 1991). Increases in [MeHg]10kDa,Food from fish and 
boiled seal intestine did not correspond to increases in the proportion of bioaccessible HgT as 
MeHg (Figure 3.1).  Similarly, the proportion of bioaccessible HgT as MeHg from raw seal liver 
increased 88% in the active colon relative to the sterile control whereas the bioaccessible MeHg 
concentration in the raw seal liver decreased 26% (Figure 3.1).   Therefore, our results suggest 
that although GI microorganisms may methylate Hg locally in the GI tract, overall the 
demethylation of MeHg in the GI tract may limit the production of MeHg.  
Food type may influence percent HgT bioaccessibility; however, the experimental design of 
this study (i.e., lack of replication within most food types) does not facilitate conclusive 
interpretations regarding the effect of food type on Hg bioaccessibility.  However, selecting two 
groups (mammal organs or Arctic char flesh) allowed us to develop hypotheses regarding food 
type effects which will be investigated in the future. Our data suggests that the small intestinal 
HgT bioaccessibility from Arctic char flesh is 6-fold greater (F1,9 = 19.17, P = 0.002) than 
observed from mammal organs (Figure 3.2).  The low variability (CV 3.1%) of duplicated 
digests of the flesh from one Arctic char sample suggests that the differences in HgT 
bioaccessibility observed between Arctic char samples are likely significant.  Furthermore, our 
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 results suggest that the GI microbial effect size on the [MeHg]10kDa,Food is 50-fold lower (F1,9 = 
6.94, P = 0.027) from mammal organs than from Arctic char flesh (Figure 3.2).  
Consequentially, the GI absorption of Hg from mammal organs is potentially lower than that of 
fish. However, the conclusive interpretation of the role of food type on Hg bioaccessibility will 
require a much larger and comprehensive set of samples than available in this study. 
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Figure 3.2 Gastrointestinal microbial effect size on small intestinal total mercury (HgT) 
bioaccessibility and bioaccessible methylmercury concentration ([MeHg]10kDa,Food) for Arctic 
char and mammal organs. Error bars denote standard error of the mean. 
We demonstrated that HgT bioaccessibility is independent of [HgT]food, for these 16 country 
food samples, thereby suggesting that the same proportion of dietary Hg is potentially available 
for absorption regardless of the Hg concentration. Furthermore, our results indicate that GI 
microorganisms may influence the speciation of dietary Hg in the intestinal lumen via the 
conversion of MeHg to HgII, although this effect appears dependent upon the type of food 
consumed. The interpretation of the speciation results were complicated by the possibility of 
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 dynamic Hg transfer between the bioaccessible (i.e., <10 kDa fraction) and non-bioaccessible 
(>10 kDa fraction). Finally, our results indicate that the bioaccessibility of HgT from mammal 
organs is lower than that of Arctic char flesh. It should be emphasized that the results of this 
study are limited by the small number of samples investigated and should not be extrapolated to 
Inuit country foods as a whole. Furthermore, it is as of yet unknown if the activity of the GI 
microbial of the SHIME is representative of Inuit GI microbial ecology. It is necessary for in 
vitro Hg bioaccessibility measured using the SHIME be validated according to in vivo Hg 
bioavailability before the results of this research be used in human health risk assessment.
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 4 GASTROINTESTINAL MICROBES INCREASE ARSENIC BIOACCESSIBILITY OF 
INGESTED MINE TAILINGS USING THE SIMULATOR OF THE HUMAN 
INTESTINAL MICROBIAL ECOSYSTEM  
4.1 Introduction 
Three million tonnes of mine tailings were generated within 64 gold-mining districts in Nova 
Scotia through mercury-amalgamation and cyanidation techniques between 1861 and the mid-
1940s (Bates 1987; Parsons 2004). Exposure to arsenic (As) through the ingestion of mine 
tailings, crushed rock waste produced during the extraction of gold from ore, poses a potential 
human health risk to communities in Nova Scotia, Canada.  Inorganic As consumption is linked 
to blackfoot disease (Tseng 2005), neonatal death and spontaneous abortions (Milton 2005) as 
well as skin, bladder, and colon cancer (Guo 2004; Tchounwou 2004). The potential for As 
exposure is exacerbated by the small particle size of tailings since the probability of ingestion 
often increases with decreasing particle size (Bright 2006). Current practice is to assume that the 
bioaccessible fraction, the fraction of an ingested contaminant solubilized in the gastrointestinal 
(GI) tract, is close to one hundred percent, or at least equal to the material used to derive the 
Toxicological Reference Value (TRV) (Ruby 1996; Yang 2003).  Since metal bioaccessibility 
varies between matrices (i.e., mine tailings, soils, etc.) there is a need to develop bioaccessibility 
estimates for use in site-specific risk assessments (Hund-Rinke 2003; Ruby 1996). 
Bioaccessibility of As has been measured using several in vitro gastrointestinal models to 
estimate human health risk from the ingestion of As-contaminated soils and mine tailings 
(Ellickson 2001; Pouschat 2006; Rodriguez 2003; Ruby 1996; Yang 2003).  The bioavailable 
fraction, that which is absorbed across the intestinal epithelium into systemic circulation, of 
metal(loid) contaminants may decrease with increasing exposure due to saturation of absorption 
mechanisms (Ellickson 2001; Ruby 1996). However, the role of As concentration in determining 
As bioaccessibility using in vitro models has been less conclusive.  Two studies utilizing 
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 different in vitro GI models demonstrated that As bioaccessibility is independent of As 
concentration (Pouschat 2006; Ruby 1996). However, when bioaccessibility was greater than the 
detection limit, decreasing bioaccessibility was observed for increasing concentrations of 
arsenate (AsV) adsorbed to the iron-oxide mineral ferrihydrite in the stomach stage of an in vitro 
model (Beak 2006b). In contrast, As bioaccessibility in soils increased with increasing 
concentrations using a different in vitro model (Yang 2003).  These conflicting results may be 
due to in vitro model differences which may have facilitated or limited As dissolution. For 
example, the pH, residence times, LSRs, and bioaccessible fraction separation procedure vary 
with in vitro models and may influence the dissolution of contaminants from soils (Oomen 2003; 
Van de Wiele 2007).  Alternatively, varying soil properties (i.e, pH and iron concentration) and 
mineralogy influence As release from soil particles (Yang 2005) as demonstrated by several 
selective sequential extraction studies (Corriveau 2006; Frau 2004). 
The chemical dissolution of As occurs as a result of desorption of surficially-adsorbed As and 
the solubilization of discrete As-bearing minerals (Rodriguez 2003). In the GI tract, chemical 
dissolution may be limited by the desorption of surficially-adsorbed As, rather than 
solubilization of discrete As minerals (Davis 1996; Ruby 1999). However, the low pH observed 
in the stomach may result in the dissolution of minerals resulting in the release of surficially-
bound As (Beak 2006b). Bioavailable As is likely composed of surficially-adsorbed As and a 
portion of the As incorporated in discrete iron-oxide As minerals (Rodriguez 2003) rather than 
from As incorporated into sulfide containing minerals (i.e., arsenopyrite) (Davis 1996; Ruby 
1999). However, not all surficially-bound As is bioaccessible since As may be strongly adsorbed 
to iron-oxide minerals (Fendorf 2004) or iron sulfide minerals (Bostick 2003). Microorganisms 
can directly solubilize arsenic by two different mechanisms involving anaerobic respiration 
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 (Oremland 2003). Firstly, dissimilatory As reducing prokaryotes (DARPs) can reduce AsV, 
adsorbed to or complexed within soil minerals, thereby releasing arsenite (AsIII) into solution 
(Ahmann 1997; Zobrist 2000).  Alternatively, dissimilatory iron reducing prokaryotes (DIRPs) 
may reduce iron, thus releasing As contained in the iron mineral (Cummings 1999). DARPs, 
such as the Bacillus sp. identified in the GI tracts of mammals (Herbel 2002) may also utilize 
iron as an electron acceptor (Oremland 2003). 
The Simulator of the Human Intestinal Microbial Ecosystem (SHIME) is unique from other in 
vitro GI models by incorporating the microbial community present in the human colon (Van de 
Wiele 2004). The conditions of the SHIME were selected from the range of physiological pH’s 
and residence times of the human GI tract likely to facilitate the dissolution of ingested 
contaminants. The small intestine stage of the SHIME includes the addition of bile salts, which 
may impact metal bioaccessibility through alterations of surface tension and the formation of 
labile bile complexes (Oomen 2004). The SHIME is operated under anaerobic conditions with 
human GI microorganisms in the colon stage, thereby facilitating the potential role of DARPs 
and/or DIRPs in contributing to As release.  The assessment of metal bioaccessibility from in 
vitro GI fluids often uses centrifugation, microfiltration (0.45 µm) or ultrafiltration for the 
separation of the bioaccessible fraction (Beak 2006b; Rodriguez 1999; Ruby 1996; Van de Wiele 
2007).  It is not clear what method best estimates bioaccessibility but ultrafiltration may be the 
most appropriate because it represents the defined size fraction known to cross the intestinal 
lumen (Van de Wiele 2007). 
For this study, we tested the hypothesis that the percent of As that is bioaccessible to humans 
from mine tailings depends on the total concentration of arsenic and the action of GI 
microorganisms.  The As bioaccessibility of two size fractions (bulk and < 38 µm) of mine 
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 tailings from three gold districts in Nova Scotia (Goldenville, Lower Seal Harbour, and 
Montague) was evaluated in the small intestine and colon stages of the SHIME.  Additionally, 
the analyses were repeated using autoclaved colon SHIME suspension to assess the influence of 
GI microbes on As bioaccessibility. 
4.2 Materials and Methods 
4.2.1 Sample description 
Mine tailings were collected from Goldenville, Lower Seal Harbour, and Montague, all 
historic gold mine sites near rural or suburban residential communities in Nova Scotia, Canada.  
This sampling was part of a large multidisciplinary study of Nova Scotia gold districts that has 
been ongoing since 2003 (Corriveau 2006; Parsons 2004).  A bulk sample of near-surface 
tailings (0-5 cm) was collected from each of the three mine tailings locations and a portion dry-
sieved to <38 microns.  The <38 µm fraction was selected since small particle sizes are more 
likely to adhere to hands and be accidentally ingested (Richardson 2006) and <38 µm was the 
finest particle size that could be obtained by dry-sieving.  Wet sieving was avoided since it may 
dissolve soluble phases and/or cause cementation.  In addition to these two size fractions, a 
cemented material (hardpan) formed by the precipitation of minerals from groundwater was 
collected from Montague. 
The mineral hosts for As in these tailings samples have been characterized using a variety of 
techniques including optical mineralogy, electron microprobe, traditional X-ray diffraction 
(XRD), sequential leach extractions, and synchrotron-based micro-XRD and micro-X-ray 
absorption near edge structure.  Detailed results of these mineralogical investigations are 
reported elsewhere (Meunier 2010; Walker 2009). Arsenic occurs naturally in the Nova Scotia 
gold deposits as arsenopyrite (FeAsS), but extensive near-surface weathering of these mine 
tailings has oxidized almost all of the sulfide to secondary phases. Minor amounts (< 2 vol.%) of 
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 sulfide minerals were observed in the samples from Goldenville and Lower Seal Harbour, 
including arsenopyrite, pyrite, pyrrhotite, and chalcopyrite.  No sulfides were identified in the 
Montague sample. The Montague tailings contain abundant hardpan material that has been 
variably crushed by off-road vehicles. The hardpan cement consists primarily of crystalline 
scorodite (FeAsO4 2H2O) and amorphous Fe arsenate. Mineralogical analyses of the Goldenville 
and Lower Seal Harbour tailings samples have identified a more diverse range of secondary 
arsenic minerals, including Ca-Fe arsenates, and Fe oxyhydroxides containing up to 30 wt % 
As2O5. These phases occur as discrete grains, reaction rims on oxidized arsenopyrite, and as 
grain coatings on silicate minerals (Walker 2009). In summary, the three samples of historical 
gold mine tailings evaluated in the present study contain a variety of arsenic-bearing minerals to 
which individuals may be exposed. The relative abundance of these phases at Goldenville, 
Lower Seal Harbour, and Montague varies laterally and vertically in the tailings deposits, and is 
not fully represented by the bulk samples collected for this study. 
4.2.2 Dynamic Simulator of the Human Intestinal Microbial Ecosystem 
As described in Section 3.2.2, a three-stage dynamic SHIME model was used to create the 
colon community used in the batch SHIME colon digests according to previously published 
procedures (Van de Wiele 2007). Stomach nutrition contained per liter: 5 g KHCO3 (Alfa Aesar), 
3 g NaCl (EM Sci), 0.5 g arabinogalactan (Sigma), 1 g pectin (Sigma), 0.5 g xylan (Sigma), 2 g 
potato starch (Nutricia), 0.2 g glucose (Sigma), 1.5 g yeast extract (Difco), 0.5 g pepton (Difco), 
2 g mucin (Sigma) and 0.25 g cysteine (Sigma).   The nutrition solution was acidified to pH 2 by 
the addition of hydrochloric acid and was then pumped into the stomach compartment and mixed 
constantly at 37ºC for two hours.  Following the stomach incubation, a pancreatic solution 
containing 12.5 g L-1 NaHCO3, 6 g L-1 Oxgall (Difco) and 0.9 g L-1 porcine pancreatin powder 
(Sigma, Belgium) was pumped into the small intestine vessel in a 2:1 (stomach: pancreatic 
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 solution) ratio, thereby creating a mixture of pH 6.5. Following a 5 hour retention time, the small 
intestine mixture was pumped into the colon compartment, which had been previously inoculated 
with a fecal culture from a healthy human adult. The fecal culture was generated according to 
previously published procedures (De Boever 2000). In brief, freshly excreted feces from a 
healthy adult male (10 g) was diluted and homogenized with sterile phosphate buffer (0.1 M, pH 
7.0, 100 mL), to which 100 mg of sodium thioglycolate was added. Particulate matter was 
removed by centrifugation (500g, 1 min) (De Boever 2000). This fecal culture was stored in 20% 
glycerol at -80°C until the time of the experiment. Following the 3 week stabilization period (De 
Boever 2000), the total aerobe and anaerobe concentrations of the colon stage were 9.9 and 10.9 
log CFU mL-1 and included microbiota such as Lactobacilli, Bifidobacteria, Enterococci, Fungi, 
Staphylococci and Clostridia. This colon digest was maintained between pH 5.6 and 5.9, as 
observed in the human ascending colon, incubated at 37°C and stirred at 150 rpm for 18 hours. 
Regular flushing of the compartments with nitrogen gas maintained anaerobic conditions. The 
redox potential of the three SHIME stages were not monitored; however, previous experiments 
have demonstrated Eh’s of -70 mV in the stomach and small intestinal compartments and -160 
mV in the colon stage. Nutrient and pancreatic solutions were maintained at 4ºC and replaced 
every 3 days. Aliquots of the suspension from the colon compartment of the dynamic SHIME 
provided the solutions used in static batch experiments to measure arsenic bioaccessibility. 
4.2.3 Static Simulator of the Human Intestinal Microbial Ecosystem 
As described in Section 3.2.3, mine tailings sample (150 mg each) was added to two 30-mL 
glass vessels for the quantification of As bioaccessibility in the small intestine and colon (Van de 
Wiele 2007).  Fasted stomach solution (6 mL) was added to each vessel. The fasted stomach 
solution is as described above except that no nutrition was added. The pH was adjusted to 1.5 ± 
0.05 with 0.5 M HCl (EMD OmniTraceTM). Anaerobic conditions were produced in the static 
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 SHIME by flushing with nitrogen gas by applying consecutive cycles of overpressure (1 bar N2-
gas; 2 min) and underpressure (1 bar vacuum; 2 min) for 30 min (Van de Wiele 2010).  The 
vessels were capped with teflon-coated lids and flushed with nitrogen gas prior to stomach 
incubation at 37ºC for 2.5 hours with rotary-mixing (10 rpm).  Following stomach incubation, 3 
mL of pancreatic solution was added to each vessel and the pH corrected to 6.2±0.05 with 0.5 M 
HCl. The vessels were then flushed with nitrogen gas and incubated for an additional 3 hours.  
Following incubation, the small intestine vessels were removed for separation of the 
bioaccessible arsenic fraction. Colon SHIME suspension (6 mL) from the Dynamic SHIME was 
added to each active colon vessel while 6 mL of previously autoclaved and cooled colon SHIME 
suspension was added to each sterile colon vessel. The pH of the colon vessels were adjusted to 
5.9 ± 0.05 with 0.5 M HCl. The vessels were then flushed with nitrogen gas for 30 minutes and 
incubated at 37ºC for 18 hours. 
4.2.4 Separation of bioaccessible fraction 
The contents of each SHIME vessel were centrifuged at 12,000g for 20 minutes, thereby 
accelerating the subsequent ultrafiltration of the SHIME solution. Less rigorous centrifugation is 
typically used in the separation of the bioaccessible fraction (Hamel 1998; Ruby 1996); however, 
this strong centrifugation was required to pellet a precipitate formed in the colon stage which, if 
present, prevented ultrafiltration. The supernatant was decanted into a test tube and weighed. 
Aliquots of the small intestine supernatant (6 mL) and colon supernatant (9 mL) were weighed 
and transferred into ultrafiltration devices (10K Microsep; Pall) which were subsequently 
centrifuged (3000 rpm). The mass of the filtrate of each sample were recorded for the As 
bioaccessibility calculation.  The As contained in the filtrate was defined as the bioaccessible As 
fraction, containing free As oxyanions and small arsenic-containing complexes. The As 
bioaccessibility (%) was calculated by: 
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Where [Filtrate As] is the As concentration (µg mL-1) in SHIME filtrate, Total As Concentration 
refers to the As concentration (mg kg-1) in the mine tailing, and the Sample Mass is the amount 
of mine tailing extracted in the Static SHIME. The Filtrate, Total Supernatant, and Total 
Ultrafiltration Mass is the mass (g) of each solution fraction assuming solution densities of 1 g 
mL-1. 
4.2.5 Measurement of arsenic via Hydride Generation Atomic Fluorescence Spectroscopy 
Digestion of the bioaccessible fraction was performed using a CEM-2000 microwave 
according to a previously published procedure, with modifications (Rahman 2000). In brief, 0.5 
mL of SHIME suspension was added to 12 M HCl (5 mL) and the mixture digested at 40% 
power for 15 minutes. Subsequently, hydrogen peroxide (EMD, 1.0 mL, 30%) was added and the 
mixture digested at 40% power for an additional 15 minutes.  A further 1.0 mL of hydrogen 
peroxide was added to the mixture, which was digested for another 15 minutes.  The digested 
SHIME solution was diluted to 30 mL with MQ water and stored at 4°C until As analysis. 
Arsenic was measured using hydride generation atomic fluorescence spectroscopy (HGAFS) 
(Millenium Excalibur, PS Analytical) (Rahman 2000). Six mL of pure OmniTrace® HCl (12N, 
37%), 4.5 mL Milli-Q® ultrapure water, and 0.4 mL 3.01 M potassium iodide (KI, EMD) and 
0.57 M ascorbic acid (C6H8O6, JT Baker) solution were added to 9 mL aliquots of each digested 
SHIME solution.  Potassium iodide served to reduce any AsV in solution to AsIII, which forms 
the hydride necessary for spectrometric analysis.  Fresh NaBH4 (1.4%, Sigma) and reagent blank 
solutions were prepared daily.  Standard solutions were prepared by dilution of stock 1000 mgL-1 
As standard (EMD Chemicals Inc., Darmstadt, Germany).  All glassware was soaked in 10% 
56 
 Omnitrace® nitric acid (EMD Chemicals Inc., Darmstadt, Germany) prior to use and then rinsed 
five times with distilled water.   
4.2.6 Quality Assurance - Quality Control  
Blank SHIME suspension (without mine tailings) was microwave digested and measured for 
As according to the procedures described above and returned an average concentration of 0.27 
µg L-1 (SE = 0.008). Duplicate SHIME subsamples were digested and measured for As for every 
ten samples processed. Additionally, a calibration blank, standard, and an analytical duplicate 
were measured for every ten samples analyzed to ensure instrumental accuracy and precision. 
The US EPA defines the methodological detection limit (MDL) as the minimum concentration 
that can be determined with 99% confidence that the true concentration is greater than zero (US 
EPA 1998). The methodological detection limit (MDL) for the measurement of arsenic in 
microwave digested SHIME solution is calculated as follows: 
MDL = (tn-1, 0.01) • sd  (Eqn 4.2) 
Where the Student’s t-value at the 0.01 level of probability for 7 samples is 3.143, and ‘sd’ is the 
standard deviation of 7 microwave digested blank SHIME solutions.  The standard deviation was 
21.5 ng L-1 for a methodological detection limit of 68 ng As L-1. 
4.2.7 Statistical analysis 
Nested factorial Analysis of Variance (ANOVA) was used to compare mean As 
bioaccessibility from the bulk and <38 µm mine tailings fractions from Goldenville, Lower Seal 
Harbour, and Montague in the small intestine and microbially active and sterile colon. ANOVA 
assumptions of normality and homogenous variance were verified using a Type I error rate of 
0.05.  Fisher’s protected Least-Significant Difference (LSD) (GLM, α=0.05) was used to test for 
significant differences. 
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 4.3 Results 
Percent As bioaccessibility was inversely related to sample As mass despite increasing As 
release (Figure 4.1).  Bioaccessibility ranged between 2.5 and 20% in the small intestine 
compared to 4 and 70% in the colon.  Bioaccessibility of As was log-normally distributed (W-
Test, P>0.05) with homogenous variance (Levene’s Test, P>0.05).  In the small intestine, there 
was little difference between the mass of bioaccessible As in the 5000 and 17000 μg As samples 
suggesting that As release had peaked by 5000 μg. In contrast, the mass of bioaccessible As 
continued to increase with increasing total As in the colon. 
Arsenic bioaccessibility in bulk tailings was greater (Fisher protected LSD, P=0.001) than in 
the <38 µm fraction in both the small intestine and colon (Figure 4.2).  No significant interaction 
in As bioaccessibility existed between mine tailings location and size fraction (GLM, P=0.814).  
Thus, the As bioaccessibility of the mine tailings locations were pooled for both the small 
intestine (n=9) and colon (n=9) stages of the SHIME.  Total As mass was consistently less in the 
bulk than in the <38 µm fraction of all mine tailings (Goldenville: Bulk = 62 µg As, < 38 µm = 
455 µg As; Montague: Bulk = 4608 µg As, < 8 µm = 16764 µg As; Lower Seal Harbour: Bulk = 
97 µg As, < 38 µm = 791 µg As). The bioaccessible arsenic concentration in the SHIME fluid 
ranged between 1.3 and 16.2 mg L-1 in the small intestine and 2.9 and 27.3 mg L-1 in the colon. 
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Figure 4.1 Relationship between As bioaccessibility (left Y-axis, closed symbols) and As 
release (right Y-axis, open symbols) and total As mass in the Small Intestine (Inverse First 
Order, R2=0.994) and Colon (Inverse Second Order, R2=0.998) stages of the SHIME for bulk 
(circle), <38 µm (triangle), and hardpan (square) fractions of mine tailings. Error bars represent 
standard error of the mean.  
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Figure 4.2 Arsenic bioaccessibility from bulk mine tailings was significantly greater 
(Fisher’s Protected LSD, P<0.001) than that of the <38 µm of the same tailings using the 
Simulator of the Human Intestinal Microbial Ecosystem. Error bars denote standard error of the 
mean. 
 
Small intestine As bioaccessibility of the bulk and < 38 µm mine tailings fractions was greater 
from Goldenville than Lower Seal Harbour which was greater than Montague (Fisher protected 
LSD, P<0.001) (Figure 4.3). The same order of As bioaccessibility was observed in the colon 
stage; however, the colon As bioaccessibility of the bulk fraction of tailings from Goldenville 
and Lower Seal Harbour were both greater (Fisher protected LSD, P<0.001) than that of tailings 
from Montague. No difference (Fisher protected LSD, P>0.05) was observed between the colon 
As bioaccessibilities of the bulk fraction of tailings from Goldenville and Lower Seal Harbour.  
In contrast, all pairwise comparisons of colon As bioaccessibility from the < 38 µm from the 
three locations were significant. The As bioaccessibility of the active colon stage of the SHIME 
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 was greater than the small intestine (Figure 4.4) for all three locations (Fisher-Protected LSD, 
P<0.001).  Sterilization of the colon SHIME suspension prior to incubation decreased As 
bioaccessibility to levels similar to the small intestine. A black precipitate was formed following 
the active colon incubation of mine tailings, but not in the absence of mine tailings.  In contrast, 
no precipitate was formed when the colon suspension was autoclaved prior to colon incubation 
with mine tailings.   
 
Figure 4.3 Mean As bioaccessibility  (± standard error) for two size fractions (Bulk, < 38 
µm) of mine tailings in the small intestine and colon stages the Simulator of the Human 
Intestinal Microbial Ecosystem.  
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Figure 4.4 Mean As bioaccessibility was greater (Fisher’s Protected LSD, P<0.001) in the 
Active Colon (i.e., with gastrointestinal microbial activity) than Small Intestine and Sterile Colon 
stages (i.e., without gastrointestinal microbial activity) of the Simulator of the Human Intestinal 
Microbial Ecosystem. 
4.4 Discussion 
As Beak et al. (Beak 2006b) observed in the gastric phase of an in vitro GI model, increasing 
As concentration decreased the percent As bioaccessibility in the small intestine of the SHIME.  
This same relationship was also observed in the colon stage of the SHIME despite increased 
solubilization of arsenic due to the activity of colon microbiota. An investigation of the 
mechanism of the relationship between As bioaccessibility and concentration will be necessary 
before conclusions may be made regarding why this inverse relationship was observed with the 
mine tailings in the SHIME but not in studies of other As-contaminated soils (Pouschat 2006; 
Ruby 1996; Yang 2003). The inverse relationship between As concentration and bioaccessibility 
in the SHIME may have arisen due to the saturation of the GI fluid or kinetic limitations of As 
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 release.  Our study used mine tailings from different sites of varying particle sizes and 
mineralogy (Corriveau 2006) and thus we are unable to construct an isotherm to assess the Kd of 
arsenic in GI fluid.   
The bioaccessibility of ingested contaminants is typically greater from small particle sizes of 
soils (Ruby 2004).  However, the As bioaccessibility from mine tailings in the SHIME was 
greater in the bulk than in the <38 µm fraction. Although this discrepancy may be due to 
differences in the mineralogy of the particle sizes, it may also be due to the high As 
concentration present in the <38 µm fraction relative to the bulk fraction. Thus, the lower percent 
bioaccessibility in small size fractions of the mine tailings may arise from the greater As 
concentrations, thereby confounding the size/bioaccessibility relationship often observed. Since 
contaminant distribution among size fractions varies between soils and size fraction affects 
probability of exposure, this result emphasizes the need to assess both the concentration and 
bioaccessible fraction distribution among various size fractions for use in human health risk 
assessment (Bright 2006; Richardson 2006). 
Inclusion of the colon stage for in vitro As bioaccessibility analyses significantly increases the 
mobilization of As from mine tailings. However, the toxicological importance of this result 
remains to be demonstrated since the principal site of As absorption is likely in the small 
intestine (Kayne 1993). Although the rate of uptake of As in the colon will be markedly reduced 
relative to the small intestine, the much longer residence time in conjunction with increased 
arsenic bioaccessibility in the colon may result in appreciable As absorption.  Additionally, 
genotoxic arsenic metabolites have been identified in the colon of mammals (Kuroda 2001; 
Kuroda 2004) and higher mortality rates due to colon cancer have been observed in populations 
that ingest high concentrations of As (Tchounwou 2004).  Previous studies have attempted to 
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 validate As bioaccessibility estimates generated with in vitro GI models with the oral 
bioavailability of ingested As from animal-dosing experiments (Ellickson 2001; Rodriguez 1999; 
Ruby 1996).  The implicit assumption of this comparison for use in human health risk 
assessment is that the GI microbiota of the animal model is functionally similar to that of 
humans.  Studies investigating the role of DIRPs and DARPs in the toxicokinetics of As 
ingestion will be necessary before conclusions regarding the validity of bioaccessibility estimates 
generated with or without the colon stage will be possible. 
The use of total As concentration from ingested soils and mine tailings results in the over-
estimation of human health risk due to the limited dissolution of contaminants from ingested soil 
particles relative to that of the soluble salts administered in toxicity studies (Hund-Rinke 2003; 
Ruby 1999). In vitro GI models such as the SHIME have gained acceptance as a valuable tool for 
estimating the relative bioavailability of As contaminated soils (Hund-Rinke 2003; Oomen 2003; 
Ruby 1999). The experiments detailed in this paper demonstrate that assumptions of constant 
bioaccessibility from varying As concentrations and size fractions could lead to inaccurate 
exposure estimates for use in risk assessments, thereby agreeing with recent recommendations 
for the incorporation of bioaccessibility estimates into human health risk assessment (Richardson 
2006).  Furthermore, neglecting to include the colon in previous assessments of As 
bioaccessibility may have resulted in an underestimation of the relative bioavailability and risk 
due to ingestion of As-contaminated soils. 
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 5 THE EFFECT OF RESIDENCE TIME AND LIQUID:SOIL RATIO ON IN VITRO 
ARSENIC BIOACCESSIBILITY FROM POORLY CRYSTALLINE SCORODITE 
5.1 Introduction 
The use of the total As concentration from contaminated particles for human health risk 
assessments potentially overestimates ingestion As exposure because only a fraction of arsenic 
present in the particle is likely to be absorbed into systemic circulation (Davis 1996; Ruby 1996). 
The fraction of a soil-borne contaminant that is absorbed into systemic circulation is defined as 
the oral bioavailability and is routinely measured using in vivo models (Davis 1996; Rodriguez 
1999). In vitro gastrointestinal (GI) models offer a means of predicting oral bioavailability via a 
surrogate measure termed bioaccessibility, which represents the fraction of a soil-borne 
contaminant released into GI fluids (Basta 2007; Jamieson 2006; Oomen 2004; Ruby 1993; Van 
de Wiele 2007). In vitro GI models offer risk assessors a means of reproducibly measuring 
bioaccessibility (and thus predicting bioavailability) without relying upon expensive and time-
consuming animal models. 
Researchers have extensively investigated factors that influence As bioaccessibility with the 
ultimate goal being the development of a predictive model of As bioaccessibility and 
bioavailability. Arsenic bioaccessibility from spiked soils is primarily determined by soil iron 
content and pH (Yang 2002; Yang 2005). Additionally, bioaccessible As from UK soils was 
successfully predicted according to several intrinsic soil components including amended soil, 
iron oxide, clay, fine grained silicate, and Fe/Al association constituents (Wragg 2007b). 
Investigations are also currently underway evaluating the role of mineralogy on As 
bioaccessibility using synchrotron-based X-Ray Absorption Near Edge Spectroscopy (XANES) 
techniques (Jamieson 2006). It is commonly presumed that particle size is inversely proportional 
to As bioaccessibility (Richardson 2006; Ruby 1999) since larger surface area facilitates 
65 
 dissolution reactions at the particle surface. However, increasing As concentration with 
decreased particle size potentially confounds, and may even reverse, the usual trend of increased 
bioaccessibility from smaller particles (Laird 2007).   
Arsenic concentration potentially affects As bioaccessibility of contaminated particles; 
however, trends from previous studies are at times inconsistent and contradictory. For example, 
As bioaccessibility either increased with increasing As concentrations in soils (Yang 2003), did 
not change with increasing As concentration (Pouschat 2006; Ruby 1996) or even decreased with 
increasing As concentrations (Beak 2006a; Laird 2007). Although it is not yet known why 
concentration only sometimes affects As bioaccessibility, operational constraints on dissolution 
(i.e., insufficient residence time, low Liquid: Soil ratio) are likely explanations since both are 
dependent upon mineralogy and soil properties. In vitro models often utilize residence times of 2 
hours for the stomach, 2 hours for the small intestine and, if included, 18 hours for the colon. 
These reflect the residence times commonly observed in humans, 0.5 - 2 hours for stomach, 2 – 6 
hours for small intestine and 12 – 24 hours for the colon. The residence times of in vitro GI 
models were selected to approximate human physiological residence times and also to be 
convenient for laboratory practice. However, if residence time is found to be a limiting factor of 
As bioaccessibility in vitro, then the upper range of human estimates should likely be adopted to 
increase conservatism. Similarly, the LSR (i.e., the ratio of fluid volume to soil mass) of in vitro 
GI models range between 40:1 and 100:1 (Van de Wiele 2007). However, this LSR is 
substantially below the range typically encountered for humans of up to 12,500:1 to 50,000:1 
(Richardson 2006). It is impractical to use a LSR of 12,500 in a normal laboratory setting 
because analytical error increases substantially as one measures soil masses below 100 mg and 
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 technical issues dominate when GI models are 1.25 to 5 L in size. However, if LSR controls As 
bioaccessibility then it may be necessary to use the 50,000:1 ratio experienced by humans. 
The objective of this research is to investigate the mechanism(s) responsible for an inverse 
relationship between As concentration and bioaccessibility. By doing so we will be able to 
determine if residence time or LSR is critical in determining As bioaccessibility. In addition, we 
will evaluate the mechanism by which GI microbes potentially increase As bioaccessibility in the 
colon. We synthesized poorly crystalline scorodite to serve as a surrogate iron mineral with As 
covalently incorporated into the mineral structure. Subsequently, we used isotherm analysis to 
investigate the mechanisms controlling As dissolution from scorodite. Additionally, we repeated 
our work with sterilized (i.e., autoclaved) SHIME solution to investigate the mechanism by 
which GI microbes increase As bioaccessibility. 
5.2 Materials and Methods 
5.2.1 Mineral synthesis 
Poorly crystalline scorodite was synthesized by mixing 0.2 M sodium arsenate (500 mL) with 
0.1 M ferric sulfate (EMD). The scorodite precipitate was collected by five successive rinse (0.1 
M sodium nitrate, EMD) and centrifuge (4000 g) cycles and the mineral was subsequently freeze 
dried. The identity of the mineral as scorodite was verified using X-Ray Diffraction. Ferrihydrite 
(2-line) was synthesized via the addition of equimolar concentrations of ferric nitrate (EMD) and 
potassium hydroxide (EMD). Potassium hydroxide was added drop-wise to ferric nitrate to bring 
and maintain the mineral suspension pH of 7.0 +/- 0.1 for one hour. As with the scorodite, the 
ferrihydrite precipitate underwent five successive rinse and centrifuge cycles prior to freeze-
drying. An As concentration gradient was established by diluting freeze-dried As-bearing 
scorodite with freeze-dried ferrihydrite to the following concentrations (% scorodite, wt/wt): 1, 
5, 10, 25, 50, 75, and 100%. The lowest As concentration was set to 1% since this amount (30 
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 mg scorodite) was as low as could be reliably and precisely weighed into the individual SHIME 
extraction vessels. 
5.2.2 Dynamic Simulator of the Human Intestinal Microbial Ecosystem 
As described in Section 3.2.2, a three compartment dynamic in vitro GI model maintained a 
microbial community representative of that found in the human large intestine. The large 
intestine microbial community was established by incubating the supernatant of a centrifuged 
mixture containing feces and a phosphate/thioglycolate buffer (De Boever 2000). The fecal 
phosphate/thioglycolate buffer supernatant (40 mL) was added to a carbohydrate-based nutrition 
solution (600 mL) in the third compartment of a series of double-jacketed reactor flasks. The 
carbohydrate solution contained 5.01 g KHCO3 (MP Biomedicals), 2.92 g NaCl (EMD), 0.5 g 
arabinogalactan (Fluka), 1.0 g pectin (ICN Biomedicals), 0.5 g xylan (Sigma), 2.1 g potato starch 
(EMD), 0.2 g glucose (EMD), 1.5 g yeast extract (BD BactoTM), 0.5 g peptone (BD BactoTM), 
2.0 g mucin (Sigma), 0.25 g L-cysteine (EM Science) per liter of Milli-Q™ water. Nutrition 
solution (100 mL), acidified to pH 2 via the addition 12 M HCl (EMD), was added to the 
stomach compartment. After 2 hours in the stomach, the acidified nutrition solution was pumped 
into the small intestine compartment where it was mixed with a pancreatic enzyme solution (50 
mL) containing 12.5 g NaHCO3 (EMD), 6.0 g Oxgall (BD DifcoTM), and 0.9 g pancreatin 
(Sigma) per liter. After two hours, the nutrition-enzyme mixture was pumped into the colon 
containing the intestinal microbial community. This feeding cycle was repeated every 8 hours. 
The SHIME was maintained at 37°C by circulating water from a heated water bath through the 
walls of the double-jacketed reactor flasks. Additionally, the anaerobic status of the dynamic 
SHIME was maintained by flushing the headspace of the reactor flasks twice daily with nitrogen. 
The microbial community contained 108 anaerobes and 108 aerobes, and included Fecal 
Coliforms, Staphylococci, Enterococci, Clostridia, and Bifidobacteria. The microbial community 
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 maintained in the colon of the dynamic SHIME was utilized in batch digests of 
scorodite/ferrihydrite mixtures. 
5.2.3 Static Simulator of the Human Intestinal Microbial Ecosystem 
As described in Section 3.2.3, synthesized mineral mixture (scorodite + ferrihydrite, total 
mass= 0.3 g) was added to 50 mL polypropylene conical bottom centrifuge tubes. Stomach 
solution (12 mL, pH 1.5) was added to each experimental unit and the pH was corrected to 1.5 
+/- 0.05 via the dropwise addition of 0.5 M HCl (EMD OmniTraceTM)/NaOH (EMD). 
Subsequently, the samples were incubated with horizontal shaking for 2 hours at 37°C to mimic 
the physiological conditions found in the stomach. After the stomach incubation, 6 mL of small 
intestinal solution (see Dynamic SHIME) was added to the scorodite stomach digests and the pH 
was corrected to 6.5 via dropwise addition of 0.5 M NaOH (EMD). Subsequently, the centrifuge 
tube headspace was replaced with N2 (Praxair) in an anaerobic chamber and the samples were 
returned to the incubator shaking for an addition 2 hours in the small intestine. After the small 
intestine residence time, 12 mL of active (i.e., non-autoclaved) or sterile (i.e., previously 
autoclaved and cooled) colon suspension from the dynamic SHIME was added to the small 
intestinal SHIME digest and the pH was adjusted to 6.3. Subsequently, the headspace of the 
centrifuge tube was replaced with N2 and the colon SHIME digests were returned to the 
incubator shaker for a final 18 hours. Following each GI stage, samples were syringe filtered 
(GMF, 0.45 um) and then a 3.5 mL aliquot of the filtered solution was passed through a 10 kDa 
membrane of an ultrafiltration centrifuge cartridge (Microsep, Pall). 
5.2.4 Chemical analysis and Quality Assurance – Quality Control 
As described in Section 4.2.5, total arsenic (AsV + AsIII) was measured using Hydride 
Generation Atomic Fluorescence Spectroscopy (HGAFS) (Millenium Excalibur, PSA) (Rahman 
2000). The 10 kDa fraction (0.5 mL) was diluted to 9 mL gravimetrically with MilliQ Water in 
69 
 50 mL polypropylene centrifuge tubes. Each sample then received 6 mL of OmniTrace HCl (12 
M), 4.5 mL of Milli-Q water, and 0.4 mL of 3.01 M potassium iodide (EMD) containing 0.57 M 
ascorbic acid (JT Baker). The potassium iodide AsV present to AsIII for measurement via 
HGAFS. Additionally, the speciation of inorganic As (i.e., percent As in the form of AsIII) was 
measured by diluting and acidifying a second aliquot (0.5 mL) of the 10 kDa bioaccessible As 
via the addition of 6 mL of OmniTrace HCl (12 M) and 4.9 mL of Milli-Q ultrapure water. The 
fluorescence measured from this second aliquot reflects the concentration of bioaccessible AsIII 
and a portion (~20%) of bioaccessible AsV. Every 10 samples, the As concentration in a blank 
(MQ water), standard, and duplicate was measured. 
5.2.5 Arsenic K-Edge X-Ray Absorption Near Edge Spectroscopy  
Arsenic K-Edge XANES spectroscopy was carried out at the HXMA beamline of the 
Canadian Light Source in Saskatoon, Canada. The ring was operating at 2.9 GeV and 250 mA, 
and data was collected in transmission mode due to the relatively high As concentrations in both 
samples and standards. SHIME samples, sorption samples, and mineral standards were analyzed 
as freeze-dried solids, whereas AsV and AsIII aqueous standards were prepared in a N2 
atmosphere using a glovebox and then analyzed in sealed 15 mL Falcon tubes at the beamline. 
Multiple scans were averaged to obtain suitable signal to noise ratio, and an Au foil standard was 
placed downstream from the sample to verify that no shifts in energy were occurring during the 
run. Data analysis was conducted with WINXAS 3.1: a linear baseline was subtracted from the 
data and the edge jump was normalized to 1.0. 
5.2.6 Statistical analysis 
Nonlinear regression analysis (NLS) was performed using R (v 2.6.0, The R Foundation for 
Statistical Computing) to evaluate the presence of an inverse relationship between As 
bioaccessibility and concentration. For the regression analysis a null intercept only model 
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 (Bioaccessibility~a) was compared to a 2-parameter reciprocal model (Bioaccessibility~a*exp(-
b*Concentration)). An F-test (α=0.05) was used to test the hypothesis that the alternative 
reciprocal model better explained the variance than the null intercept model via residual sum of 
squares. Similarly, nonlinear regression analysis (NLS) was performed using (version 2.6.0, The 
R Foundation for Statistical Computing) to determine if the As dissolution isotherms deviated 
from the equation of a straight line. For the regression analysis a null linear model was compared 
to a 2-parameter exponential rise to a maxima model using (version 2.6.0, The R Foundation for 
Statistical Computing) for the stomach, small intestine, and sterile colon isotherm. In contrast for 
the active colon, a 3-parameter logistic sigmoidal alternative model was selected since it best 
explained the variance. An F-test (α =0.05) tested the hypothesis that the alternative exponential 
and sigmoidal models better explained the variance via residual sum of squares. Finally, a 
Fisher’s Protected LSD (α = 0.05) was performed to compare As bioaccessibility and percent of 
bioaccessible AsIII with or without GI microbial activity. 
5.3 Results 
An inverse relationship between As concentration and bioaccessibility was observed in the 
stomach (F1,12=126; P=1x10-7), small intestine (F1,12=1061; P=4x10-13), and colon (F1,12=362; 
P=2x10-10) following the digestion of scorodite using the SHIME (Figure 5.1). Scorodite As 
bioaccessibility ranged between 0.1 to 6.6% in the stomach, 1.4 to 83.5% in the small intestine, 
and 2.4 to 94.8% in the colon. Similarly, an inverse relationship was observed between As 
bioaccessibility and concentration in the stomach, small intestine, and colon following the 
SHIME digestion of As adsorbed on ferrihydrite, an iron hydroxide (Figure 5.2). As 
bioaccessibility from synthesized scorodite was as much as 14-fold higher than previously 
reported from natural samples (Jamieson 2006; Laird 2007), likely due to the relatively low 
crystallinity of the freshly-synthesized scorodite used for this study. 
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Figure 5.1 Inverse relationships were observed between As percent bioaccessibility (± 
standard deviation) and total As concentration (X-axis) of synthesized poorly crystalline 
scorodite in stomach (F=126; P=1x10-1), small intestine (F=1061; P=4x10-3) and colon (F=362; 
P=2x10-10) stages of the Simulator of the Human Intestinal Microbial Ecosystem. 
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Figure 5.2.  Mean Arsenic bioaccessibility (± standard deviation) of Arsenic-bearing 2-line 
ferrihydrite is inversely related to total As concentration in the Simulator of the Human Intestinal 
Microbial Ecosystem. 
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 Naturally occurring scorodite is typically more crystalline and less soluble (Harvey 2006), 
thereby causing lower As bioaccessibility. Despite these differences in solubility between natural 
occurring scorodite and the poorly crystalline scorodite, the inverse relationship between As 
concentration and bioaccessibility is consistent with that of natural samples (Laird 2007). As 
shown in Figure 5.3, the dissolution isotherm of scorodite describing the release of As into the 
stomach fluids is best explained by a linear relationship (F1,12=2.52; P=0.14). Therefore, all of 
the reactions controlling the dissolution of As from scorodite may have reached equilibrium 
under simulated stomach conditions without reaching a asymptotic solubility limit. 
Consequentially, stomach As bioaccessibility from scorodite was not likely limited by kinetic 
constraints under simulated stomach conditions. However, it is important to note that non-linear 
isotherms are also possible at equilibrium. Additionally, these results suggest that increasing the 
LSR (i.e., adding more gastric fluid) may increase As solubilization and bioaccessibility. 
Therefore, researchers should measure As bioaccessibility at higher LSR when an inverse 
relationship is observed between concentration and bioaccessibility, in agreement with previous 
work (Richardson 2006).  
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Figure 5.3 Isotherms depicting the relationships between scorodite As concentration (Y-axis) 
and the bioaccessible As concentration (± standard deviation) using the Simulator of the Human 
Intestinal Microbial Ecosystem. Isotherms were best represented by a straight line in the stomach 
stage (P=0.14), exponential rise to a maxima in the small intestine (P=2x10-9) and sterile colon 
(P=2x10-7) stages, and a logistic sigmoidal model for the active colon stage (P=2x10-7).  
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In contrast to the stomach, a 2-parameter exponential rise to a maxima model better explained 
the release of As from scorodite in the small intestine isotherm (F1,12=246; P=2x10-9). The 
isotherm’s deviation from linearity suggests that equilibrium was not reached following small 
intestinal digestion of scorodite through the SHIME. Therefore, the As dissolution in the small 
intestine is potentially limited by residence time instead of LSR. The isotherm of As dissolution 
in the active colon of the SHIME (i.e., with microbial activity) was better explained by a 3 
parameter logistic sigmoidal model (F2,11=25.8; P=7x10-5) than a linear model. In contrast, the 
isotherm of As dissolution in the sterile colon of the SHIME (i.e., without microbial activity) was 
better explained by a 2-parameter exponential rise to a maxima than with a linear model (F1,12 
=108; P=2x10-7). This suggests that microbial activity alters the dissolution kinetics of As from 
scorodite; however, the long colon residence time does not facilitate all dissolution processes to 
reach equilibrium. Based upon the isotherm of scorodite in the stomach, small intestine, and 
colon, only evaluating the role of LSR without considering the effect of residence time upon As 
bioaccessibility may cause the systematic underestimation of As bioaccessibility when in vitro 
As dissolution is limited by reaction kinetics (i.e., when the isotherm is nonlinear).   
Depending upon As concentration in the sample, As bioaccessibility was greater in the colon 
than in the small intestine which was greater than observed in the stomach, reflecting the 
chemical and microbiological conditions of each stage. Solid phase As K-Edge XANES 
spectroscopy that the As spectra of scorodite digested through the SHIME was most similar (e.g 
position of edge, shape of post-edge spectral fingerprint) to AsV adsorbed on ferrihydrite (Figure 
5.4). This result is consistent with scorodite dissolution and subsequent re-precipitation reactions 
as follows. The low pH of the stomach SHIME facilitated the dissolution of scorodite (Harvey 
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 2006), thereby releasing As into gastric fluids. Subsequently, the adsorption of aqueous As onto 
existing or newly precipitated ferrihydrite  
  
Figure 5.4 X-Ray Absorption Near-Edge Spectroscopy (XANES) of As bearing minerals 
digested through the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). The left 
panel depicts several arsenic-bearing standards whereas the right panel shows scorodite digested 
through the SHIME. 
 
potentially caused the relatively low As bioaccessibility observed in the stomach. The addition of 
HCO3- from the small intestine raises pH and also competes with AsV for sorption sites, thereby 
explaining the increased As bioaccessibility in the SHIME small intestine. The displacement of 
AsV with bicarbonate (Stachowicz 2007) on ferrihydrite may have caused, in part, the inverse 
relationship between As concentration and small intestinal As bioaccessibility since 
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 displacement would be higher (via simple mass action) at low As surface loadings relative to 
high As surface loadings. 
 
5.4 Discussion 
Microbial activity increased scorodite As bioaccessibility up to two-fold relative to sterile 
controls; however, the impact of microbial activity depended upon the As concentration of the 
sample (Figure 5.1). At the lowest concentration (5x103 mg kg-1), As bioaccessibility from 
scorodite in the active and sterile colon of the SHIME were equivalent (Fisher Protected LSD, 
P>0.05). Similarly, at very high As concentrations (> 1x105 mg kg-1) there was no difference 
(Fisher Protected LSD, P>0.05) in As bioaccessibility from scorodite with or without the activity 
of GI microorganisms. In contrast, when scorodite As concentrations were between 5x103 mg kg-
1 and 1x105 mg kg-1 the bioaccessibility of As increased (Fisher Protected LSD, P<0.05) between 
56 and 110% relative to sterile controls. These results are in contrast to those observed from 
natural scorodite from gold mine tailings, containing between 380 and 1x105 mg kg-1 As, where 
GI microbes increased As bioaccessibility between 140 and 300% (Laird 2007). The diminished 
effect of GI microbes on synthesized scorodite As bioaccessibility at sample As concentrations 
less than 5x103 mg kg-1 was likely due to the high small intestinal bioaccessibility observed from 
the freshly synthesized scorodite in comparison to more crystalline mine tailings. In contrast, GI 
microorganisms negligible affect on As bioaccessibility from freshly synthesized scorodite with 
high As concentrations (> 1x105 mg kg-1) may be due to As-induced toxicity to the GI 
microorganisms. 
Bioaccessible arsenite was observed in both the active and sterile colon following the 
digestion of scorodite containing between 2x104 and 3x105 mg kg-1 As through the SHIME 
despite all As from scorodite originating as AsV (Figure 5.5). Therefore, the reducing conditions 
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 of the GI tract, even without the activity of GI microorganisms, may reduce AsV to AsIII. AsV 
reduction to AsIII tended to be higher in the presence of GI microorganisms at As concentrations 
less than 3x105 mg kg-1 in the sample; however, the difference was not significant (F1,6=0.46; 
P=0.52). Furthermore, the main peak energy of the unaltered scorodite, scorodite digested 
through the active colon, and scorodite digested through the sterile colon corresponds to AsV 
being dominant in all samples (Figure 5.4). Consequentially, AsIII was not measurably 
precipitated in Fe(II) or Fe(III) minerals in the colon SHIME.  Notably, the transmission XANES 
spectra of scorodite digested through the active and sterile SHIME colon are similar to that of 
AsV adsorbed on ferrihydrite.  This reflects the dissolution of scorodite and subsequent 
adsorption of AsV on the sparingly soluble ferrihydrite.  Therefore, although AsV may be reduced 
to AsIII in the SHIME, the reduction is neither associated with microbial activity nor related to 
the increased As bioaccessibility observed in the SHIME colon. 
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Figure 5.5 Gastrointestinal microbes did not increase the percent of bioaccessible As as AsIII 
(± standard deviation) for scorodite digested in the Simulator of the Human Intestinal Microbial 
Ecosystem (F=0.46; P=0.52). 
This research demonstrated that inverse relationships between concentration and 
bioaccessibility are possible both for particles with surficially adsorbed As (ferrihydrite) and 
particles with As incorporated into its structure (scorodite). The isotherms for As dissolution 
from scorodite indicated that only evaluating the role of LSR without considering residence time 
may cause the systematic underestimation of As bioaccessibility when in vitro As dissolution is 
limited by reaction kinetics. Therefore, we recommend researchers evaluate the effect of 
residence time and LSR on As bioaccessibility as a regular part of in vitro bioaccessibility QA-
QC.  Since As reducing bacteria were not responsible for the increases in As bioaccessibility, 
dissimilatory iron reduction is the most likely alternative mechanism explaining increased As 
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 bioaccessibility in the colon. Future research will be conducted to confirm that iron reducing 
bacteria are responsible for increased As bioaccessibility observed in the SHIME. 
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 6 INCREASED ARSENIC BIOACCESSIBILITY DUE TO MICROBIAL ACTIVITY DOES 
NOT AFFECT ARSENIC BIOAVAILABILITY 
6.1 Introduction 
Elevated soil arsenic (As) concentrations due to industrial and mining operations can present 
human health risk to affected communities via the accidental ingestion of contaminated soil of 
individuals, especially children. Oral As exposure due to the accidental ingestion of 
contaminated soils is calculated according to the soil As concentration (Cs), the soil ingestion 
rate (IRs), and As relative bioavailability (RBA) (Casteel 2001; Health Canada 2004a; Ruby 
1999). As RBA is defined as the fraction of ingested As from contaminated soil that reaches 
systemic circulation divided by the fraction of ingested As from sodium arsenate that reaches 
systemic circulation. Preliminary Quantitative Risk Assessments typically require the 
conservative and protective assumption that the RBA of ingested As is 100% (Health Canada 
2004a). However, in more detailed risk assessments (e.g., Site Specific Risk Assessments or 
SSRA), risk assessors may account for limitations on GI absorption when calculating oral As 
exposure (US EPA Region 8 2005). As RBA is measured according to in vivo dosing trials to 
derive the As Urinary Excretion Fraction (UEF), which represents the fraction of ingested As 
excreted into the urine of exposed animals (Casteel 2001; Rodriguez 1999). The As RBA is then 
calculated by dividing the UEF of animals exposed to As from soil by the UEF of animals 
exposed to sodium arsenate. The ratio of the UEFsoil:UEFarsenate is equivalent to the As RBA since 
the extent of tissue binding, biliary excretion, and excretion in hair is assumed equivalent 
between the soil and sodium arsenate treatment groups.   
The bioaccessibility of As, defined as the fraction of ingested As solubilized into 
gastrointestinal (GI) fluids, is a conservative surrogate and in vitro alternative to bioavailability 
trials that rely upon animal testing. In vitro GI models (e.g., Physiologically Based Extraction 
82 
 Test or PBET; Simple Bioaccessibility Extraction Test or SBET; Ohio State University In Vitro 
Gastrointestinal or OSU-IVG method; and Simulator of the Human Intestinal Microbial 
Ecosystem or SHIME, etc) are often used for measuring As bioaccessibility by simulating the 
physical, chemical, and enzymatic conditions of the human GI tract (Basta 2007; Juhasz 2007; 
Ruby 1996; Van de Wiele 2007). Of the in vitro methods listed above, only the SHIME 
incorporates the function of aerobic and anaerobic microorganisms present in the distal GI tract 
(De Boever 2000). This could be of particularly importance for estimating As bioaccessibility 
since GI microorganisms may affect ingested As speciation (Kuroda 2001), thereby altering As 
toxicokinetics (Cohen 2006).  In addition, in vitro GI microbial activity under simulated colon 
conditions often increases As bioaccessibility from soils, as demonstrated for: mine tailings, a 
contaminated agricultural soil, an ironstone soil containing elevated arsenic concentrations, 
synthesized amorphous scorodite (FeAsS), and synthesized 2-line ferrihydrite with surficially 
adsorbed arsenate (Laird 2010; Laird 2007; Laird 2009). Consequentially, in vitro GI models that 
neglect to incorporate microbial activity may underestimate As bioaccessibility for human health 
risk assessment.  
Although in vitro microbes commonly increase As bioaccessibility under simulated colon 
conditions; incorporating microbial activity into in vitro GI models has not been widely adopted 
since the relevance of colon As bioaccessibility is unknown (Laird 2007). Specifically, there is 
little evidence as to whether As that is mobilized by microbial activity is, thereafter, absorbed 
into systemic circulation. Recent publications describing the role of GI microbial activity on As 
bioaccessibility from soils have utilized microbial communities and physiological conditions 
representative of those found in the human large intestine (Laird 2010; Laird 2007; Laird 2009). 
However, it is the small intestine that is thought to be the dominant site of GI As absorption due 
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 to its large surface area and high efficiency of phosphate absorption (Kayne 1993), which is a 
surrogate for As absorption (Rosen 2002; Wu 2007). However, even without colonic As uptake, 
GI microbial activity may contribute to the bioavailability of ingested soil-borne As since the 
distal small intestine (e.g., ileum), like the large intestine, possesses a large and diverse 
community of aerobic and anaerobic bacteria under reducing conditions (Booijink 2007; 
Quintanilha 2007). Furthermore, the sizeable surface area and expression of the phosphate 
transporter NaPiIIb in the ileum (Sabbagh 2009) would likely make microbially-mediated 
increases in As bioaccessibility under simulated ileal conditions to be of utmost toxicological 
relevance.    
The primary objective of the research presented in this manuscript was to evaluate whether or 
not it is necessary for measures of As bioaccessibility to account for GI microbial activity. To do 
this, we conducted in vitro and in vivo experiments to evaluate the toxicological relevance of GI 
microbes to As bioaccessibility and bioavailability. For the in vitro experiment, we compared As 
bioaccessibility with and without an ileal microbial community to assess the role of microbes in 
a GI stage known to contribute to bioavailable As. For the in vivo experiment, we compared the 
urinary As excretion of juvenile swine (with and without oral antibiotic treatment) orally 
exposed to soil-borne As. We hypothesized that both in vitro As bioaccessibility and in vivo As 
bioavailability are affected by GI microbial activity, indicating that in vitro models should 
include GI microbes to ensure SSRAs are sufficiently protective of human health. 
6.2 Materials and Methods 
6.2.1 Soils 
For the in vitro Ileum SHIME experiment, twenty soils were collected from urban residential 
neighborhoods in Hoboken, Belgium that were historically contaminated from industrial 
operations. Three of the Hoboken soils (H5, H18, and H50) containing elevated As 
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 concentrations (i.e., greater than the As CCME Soil Quality Guideline (SQG) of 12 mg kg-1) 
(CCME 2007) were selected for the research described in this manuscript. The soils were dry-
sieved (<100 µm) to better reflect the size fraction most likely to adhere and then be accidentally 
ingested through hand-to-mouth behaviour (Bright 2006; Siciliano 2009). Additionally, a 
standard reference material (BGS 102) was obtained from the British Geological Survey. For the 
in vivo juvenile swine dosing trial, overburden from an abandoned gold and silver mine in Mount 
Nansen, YK was collected and sieved to <250 µm. The overburden (TM1) was collected as part 
of a comprehensive human and environmental risk assessment conducted for the site. Arsenic 
concentrations in each of the soils are listed in Table 6.1.   
Table 6.1 Arsenic concentration in the bulk and <100 µm fractions of three Hoboken Soils 
(H5, H18, and H50), one standard reference soil (BGS 102), and one mine overburden (TM1). 
*YK1, used for the in vivo dosing trial, was sieved to <250 µm. 
 H5 H18 H50 BGS 102 TM1 
Bulk Soil  33 27 48 101 3940* 
100 µm Sieved  35 35 115   
 
6.2.2 Dynamic Simulator of the Human Intestinal Microbial Ecosystem 
As described in Section 3.2.2, the microbial community from the human GI tract was cultured 
using the SHIME according to previously published procedures (De Boever 2000). In brief, the 
SHIME microbial community was established by mixing human fecal matter, which was freshly 
voided by an adult male volunteer, in a phosphate/thioglycolate buffer. The fecal mixture was 
subsequently centrifuged and the supernatant (40 mL) was added to a carbohydrate-based 
nutrition solution (600 mL) in the third compartment of a series of double-jacketed reactor 
flasks. The carbohydrate nutrition contained per liter of distilled water: 5.01 g KHCO3 (MP 
Biomedicals), 2.92 g NaCl (EMD), 0.5 g arabinogalacatan (Fluka), 1.0 g pectin (ICN 
Biomedicals), 0.5 g xylan (Sigma), 2.1 g potato starch (EMD), 0.2 g glucose (EMD), 1.5 g yeast 
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 extract (BD BactoTM), 0.5 g peptone (BD BactoTM), 2.0 g mucin (Sigma), and 0.25 g L-cysteine 
hydrochloride (EMD). The SHIME microbial community was fed by pumping 100 mL of pH 2 
nutrition into the first compartment (i.e., stomach stage) of the double-jacketed reactor flask. 
After two hours in the simulated stomach stage, the solution was pumped into the second 
compartment (i.e., duodenum stage). Therein, the carbohydrate solution was mixed with a 
pancreatic enzyme solution (50 mL) containing per liter: 12.5 g NaHCO3 (EMD), 6.0 g Oxgall 
(BD DifcoTM) (dehydrated bile salts), and 0.9 g pancreatin (Sigma). Following an additional 2 
hours in the simulated duodenum stage, the mixture was pumped into the third compartment (i.e., 
colon stage) containing the human fecal microbial community. This feeding schedule was 
repeated every 8 hours.  
The pH of the simulated colon compartment was maintained between 5.9 and 6.3 using a pH 
controller (Consort R305). The temperature of the SHIME was set to 37°C using a circulating 
heated water bath and the anaerobic status (-196 ± 9 mV) of the system was maintained via daily 
headspace purges with N2 gas. The colon microbial community contained 8.7 log CFU mL-1 total 
aerobes and 8.8 log CFU mL-1 total anaerobes and included Lactobacilli, Fecal Coliforms, 
Clostridia, Staphylococci, Enterococci, Bifidobacteria, Klebsiella, and Veillonella. 
6.2.3 Static Simulator of the Human Intestinal Microbial Ecosystem 
The bioaccessibility of As from the three Hoboken soils and BGS 102 was measured in the 
Stomach SHIME, Duodenum SHIME, Ileum SHIME, and Colon SHIME using a batch design as 
described in Section 3.2.3. Previously published SHIME procedures (Laird 2010; Van de Wiele 
2007) were modified to include a novel microbially-active stage representative of conditions 
present in the distal human small intestine (i.e. ileum). In brief, 0.3 g of each soil was added to 
acid-washed 150-mL glass bottles for the 4 stages of the SHIME. For the Stomach SHIME, 30 
mL of pH 1.4 HCl was added to each bottle and the pH of the soil slurry was then adjusted to 1.5 
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 ± 0.1 via the dropwise addition of 0.5 M HCl (EMD)/NaOH (EMD). The bottles were then 
capped, flushed with N2 (30 min, 1 bar), sealed, and then incubated at 37°C with horizontal 
shaking (130 rpm). After two hours of incubation in the Stomach SHIME, 15 mL of pancreatic 
enzyme solution was added to each bottle and the pH was adjusted to 6.5 ± 0.2. The bottles were 
subsequently flushed with N2 and incubated with shaking for an additional 1, 2, or 3 hours for 
the Duodenum SHIME. Thereafter, 15 mL of ileum suspension (8.6 g L-1 K2HPO4 (EMD), 6.8 g 
L-1 KH2PO4 (EMD), 3 g L-1 Oxgall (BD DifcoTM), 1 g L-1 mucin (Sigma), 0.5 g L-1 L-cysteine 
HCl (EMD), and 0.15 mL dynamic SHIME colon suspension) was added to each bottle. The pH 
of the solution was adjusted to 6.8 ± 0.2 and the bottles were flushed with N2 and incubated for 
an additional 5, 4, or 3 hours for the Ileum SHIME. Three small intestinal residence time 
treatments were performed (e.g., 3 hr Duodenum SHIME + 3 hr Ileum SHIME, 2 hr Duodenum 
SHIME + 4 hr Ileum SHIME, or 1 hr Duodenum SHIME + 5 hr Ileum SHIME) to determine 
whether increasing microbial activity duration increases As bioaccessibility. After the 
completion of the Ileum SHIME, 30 mL of colon suspension from the dynamic SHIME was 
added to each bottle and the pH of the solution was adjusted to 6.3±0.2. The bottles were once 
again, capped, flushed with N2, and incubated for a final 18 hours.  
After each of the 4 stages of the SHIME (Stomach, Duodenum, Ileum, and Colon), the 
bioaccessible arsenic fraction was separated with syringe microfiltration (0.45 µm, Whatman, 
GMF) and a 10 mL aliquot of the bioaccessible fraction was acidified via 0.5 mL of 12 M HCl 
(EMD, OmniTraceTM). The acidified samples were frozen until measured for aqueous total As 
concentrations. The role of microbial activity on As bioaccessibility was evaluated by repeating 
Ileum SHIME treatments using aliquots of SHIME suspension that were previously autoclaved. 
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 Each treatment was conducted in triplicate for the three Hoboken soils whereas the treatments 
were unreplicated for BGS 102.  
6.2.4 Animals, housing, and feed 
The in vivo As dosing procedures were based upon methods developed by Dr Stan W Casteel 
at the University of Missouri (Basta 2007; Casteel 2001; US EPA Region 8 2005). Eleven 
healthy male swine (8 week-old; initial body weight ~24 kg) were obtained from the Prairie 
Swine Center, Inc (PSCI). The animals were housed in individual metabolic cages (1.5 x 1.5 x 
0.9 m) at the PSCI equipped with screened collection pans to facilitate the separation and 
quantitative collection of urine. The pens were maintained in the thermo-neutral zone of the pigs 
with the lights on a 14:10 hr (light:dark) cycle. The swine were previously weaned onto an 
antibiotic-free stage 3 starter ration pig chow provided by the PSCI and municipal drinking water 
was provided to each animal ad libitum. During the three-week experiment, each animal was fed 
two equal portions of feed daily in the morning and evening. Their daily feed intake was 
restricted to 4% body weight to encourage them to completely consume their molasses-ball 
dosing vehicle.  
6.2.5 In vivo arsenic exposures 
The health of the animals was monitored for six days prior to the onset of arsenic exposure to 
ensure each animal successfully adjusted to their enclosures. After the six day monitoring period, 
the animals were randomly assigned to one of three treatment groups: arsenic (via TM1) plus 
antibiotics (AB2-TM1; n=4), arsenic (via TM1) without antibiotics (AB0-TM1 n=4), and a 
negative control group (AB0-CON; n=3). The negative control group animals were administered 
neither antibiotic nor arsenic. The molasses treats used to administer the antibiotics/As were 
made by thoroughly mixing equal portions of pig chow, rolled oats, and molasses into a thick 
malleable dough. These molasses treats were used as a dosing vehicle rather than the more 
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 commonly used dough-ball (Basta 2007) since molasses was better able to mask the bitter flavor 
of metronidazole.  
The antibiotic treatment procedure used to modify the GI microbial communities of the 
juvenile swine was designed in consultation with Dr. Chris Clark (DVM, University of 
Saskatchewan). Neomycin (Soluble Neomix Powder) was selected because it is commonly given 
orally to pigs to treat enteric infections and is broadly effective against gram-negative bacteria 
and some gram-positive bacteria. Furthermore, neomycin was previously used to successfully 
show the importance of GI microorganisms for Hg toxicokinetics (Rowland 1980). 
Metronidazole (Apotex Inc, DIN 00545066) was also included in the antibiotic treatment 
regimen due to its high efficacy against anaerobic intestinal microflora (Lofmark 2010). Since 
this same group of microbes (i.e., faculative anaerobes, namely DIRPs) was thought to be 
responsible for the mobilization of metals from contaminated sediments (Oremland 2005), 
metronidazole was deemed likely to cause microbial community shifts relevant to As 
toxicokinetics. It must be remembered, however, that metronidazole is not approved for 
treatment of swine since it is not food-safe. Therefore, special approval was obtained to treat the 
swine with metronidazole on the condition that all animals would be destroyed at the end of the 
study and not enter the food supply. The dosages of the two antibiotics were initially set at 30% 
above the therapeutic dose for neomycin (30 mg kg-1 d-1) (Drugs.com 2010) and metronidazole 
(53 mg kg-1 d-1) (Clark 2010). After 7 days of treatment, the antibiotic dosages were increased to 
twice the therapeutic doses for neomycin (45 mg kg-1 d-1) and metronidazole (80 mg kg-1 d-1) to 
maximize the effects upon the GI microbial communities of the juvenile swine. 
For animals in the AB2-TM1 treatment group, neomycin and metronidazole was hand-mixed 
into the molasses treat mixture described above. Similarly, TM1 was added to the molasses treat 
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 mixture for animals in the AB2-TM1 and AB0-TM1 treatment groups. AB2-TM1 and AB0-TM1 
animals were orally exposed to 160 µg As kg BW-1 day-1 from the Yukon overburden mixed into 
the molasses-balls. The molasses treat mixture containing antibiotic and/or As doses were 
divided into two equal portions, the first of which was administered (by hand) prior to morning 
feeding whereas the second was administered prior to evening feeding. This dosing procedure 
was continued for 14 days to facilitate urinary As excretion to reach steady state. 
During the 14-day exposure period, swine urine was collected over three 48-hr intervals (D7-
8, D10-11, and D13-14) into large polypropylene containers. The volume of excreted urine for 
each animal was measured for each of the three urine collection periods. Subsequently, two 50-
mL aliquots of urine were transferred into disposable polypropylene centrifuge tubes and were 
acidified (2% HCl) and frozen until microwave digestion and As quantification. After the 14-day 
exposure period, the animals were euthanized via captive-bolt and exsanguination. Subsequently, 
the animals were dissected and a 10-cm segment of the proximal colon was isolated and excised. 
Three 40-mL subsamples of intestinal contents were collected and transferred into disposable 
polypropylene centrifuge tubes. The tubes were immediately flash-frozen in liquid nitrogen and 
stored at -80°C until subsequent denaturing gradient gel electrophoresis (DGGE) analysis. 
6.2.6 Arsenic quantification 
The acidified SHIME fluids for BGS 102 and the three Hoboken soils were microwave 
digested prior to As quantification via Hydride Generation Atomic Fluorescence Spectroscopy 
(HGAFS). The microwave digestion procedure required 2 mL of the acidified SHIME samples to 
be added to 10 mL of 12 M OmniTrace HCl (EMD) in Teflon-coated digestion tubes (Xpress, 
CEM). H2O2 (EMD, 30%, 1 mL) was added to each of the digestion tubes to initiate the 
oxidation of precipitated organic matter. After allowing 15 min for the reaction to subside, 
another 1 mL aliquot of H2O2 was added to each tube. The tubes were capped, sealed, and then 
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 digested at 100% power (1600 Watts, 100°C, Timeramp = 10 min, Timehold = 40 min) in a MARS-
5 microwave (CEM). The microwave digested SHIME solutions were diluted and transferred to 
disposable polypropylene centrifuge tubes for analysis via HGAFS. Bioaccessible As from the 
three Hoboken soils and BGS 102 were measured via HGAFS using a previously published 
procedure (Rahman 2000). In brief, inorganic As in the microwave digested SHIME samples 
was reduced to arsenite (AsIII) via the addition of a KI solution (50% w/v, EMD) containing 
10% ascorbic acid (JT Baker). Thereafter, the aqueous As concentration in each of the 
microwave digested SHIME samples was measured using a Millenium Excalibur (PS 
Analytical). Percent As bioaccessibility was calculated according to the equation: 
  100%
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μ
μ   (Eqn 6.1) 
The acidified urine of the juvenile swine collected during the in vivo As dosing trial was 
microwave digested prior to quantification via Inductively Coupled Plasma Mass Spectrometry 
(ICPMS). Pig urine (2 mL) was added to 3 mL of HNO3 (16 M, EMD OmniTrace) and 0.5 mL 
of H2O2 (EMD) in Teflon-coated digestion tubes (Xpress, CEM). The tubes were capped, sealed, 
and transferred into MARS-5 microwave (CEM) and digested using a 2-stage procedure at 100% 
power (1600 Watts, TimeRamp-1&2=15 min, TimeHold-1&2=30 min, Temp1=180°C, Temp2=160°C). 
The digested samples were transferred to 15-mL polypropylene centrifuge tubes and diluted to 
2% HNO3 (EMD) for ICPMS analysis. Swine, like humans and other mammals, convert ingested 
inorganic arsenic into methylated arsenic metabolites (Cohen 2006). Since such methylarsenicals 
do not form arsenic hydrides when mixed with sodium borohydride, the use of HGAFS (as 
described in Chapter 4 and 5) does not provide adequate recovery of arsenic in pig urine (ie. a 
large fraction of the excreted As is not detected). Therefore, urinary As concentrations were 
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 measured using ICPMS to ensure complete recovery of methylated As metabolites present in the 
swine urine. Urinary As excretion was calculated according to the equation: 
( ) ( ) mLgionConcentrat Arsenichr mLUrinehr) 48g( Excretion urinevolume μμ ×= 48   (Eqn 6.2) 
 
6.2.7 Statistical analysis 
Normality (Kolmogorov-Smirnov, p>0.05) and homogeneity of variance (Levene Median, 
p>0.05) assumptions for As bioaccessibility and urinary As excretion were confirmed using 
SigmaStat v3.1. Two-way Analysis of Variance (ANOVA) was used to evaluate the effects of 
microbial activity and ileum residence time on the bioaccessibility of As from each of the three 
Hoboken soils (SigmaStat v3.1). Pairwise multiple comparisons were performed using the Holm-
Sidak method (overall significance level = 0.05). Similarly, a two-way ANOVA was used to 
evaluate the role of antibiotic co-administration and urine collection period on the urinary As 
excretion of swine orally exposed to TM1. 
6.2.8 Quality Assurance – Quality Control  
The standard reference material BGS 102 was digested in the SHIME as a positive control for 
each treatment batch of Hoboken soils to check the consistency of As bioaccessibility results 
with those of previous studies. Each SHIME treatment batch also included a blank (i.e., no soil 
added) and sodium arsenate spike. The methodological detection limit (MDL) of As in the 
SHIME fluid was 181 ng L-1. Average spike recovery of sodium arsenate was 81%. HGAFS 
instrumental precision was monitored by re-measuring one for every 15 samples. Mean deviation 
of duplicates was 3.0%. The bioaccessibility of As from BGS 102 and the three Hoboken soils 
was corrected according to the As concentrations measured in the procedural blanks. The spike 
recovery of MMA and DMA in swine urine measured via ICPMS was 118 and 121%, 
respectively. The MDL of arsenic in swine urine collected at the PSCI was 292 ng L-1. 
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 6.3 Results 
Percent As bioaccessibility of the three Hoboken soils ranged between 17 - 66% in the 
Stomach SHIME, 14 - 51% in the Duodenum SHIME, 21 - 68% in the Ileum SHIME, and 26 – 
77% in the Colon SHIME (Table 6.2). In contrast, the As bioaccessibility of BGS 102 was 
considerably lower in the Stomach SHIME (2.0 %), Duodenum SHIME (1.0 %) and Ileum 
SHIME (3.1 %). However, the As bioaccessibility of BGS 102 in the Colon SHIME increased to 
values similar as those observed for the Hoboken soils. Notably, the Hoboken soil with the 
greatest As bioaccessibility (H50) also had the greatest As enrichment (i.e. (sievedAs-
bulkAs)/bulkAs) and As concentration. 
Table 6.2 Mean (± standard error) percent bioaccessibility of three Hoboken soils (H5, 
H18, H50; n=3) and one standard reference material (BGS 102; n=1* or 3) digested through 
successive stages of the Simulator of the Human Intestinal Microbial Ecosystem. 
 
GI Stage H5 H18 H50 BGS 102 
Stomach SHIME 24.6 (0.6) 16.5 (0.8) 66.4 (4.8) 2.0* 
Duodenum SHIME 15.7 (1.6) 13.8 (3.2) 36.8 (5.5) 1.0* 
Ileum SHIME 23.5 (0.5) 21.0 (0.4) 67.6 (1.5) 3.1* 
Colon SHIME 26.4 (1.0) 28.5 (1.1) 77.3 (3.8) 29.6 (3.4) 
 
When the Ileum SHIME residence time was 4 hours, microbial activity increased the release 
of As from H5 (Holm-Sidak, p<0.001), H18 (Holm-Sidak, p=0.001) and H50 (Holm-Sidak, 
p=0.004), thereby increasing percent As bioaccessibility (Figure 6.1). This microbial activity 
was associated with the formation of black precipitate, as previously observed in the Colon 
SHIME (Laird 2007), despite the Ileum SHIME’s considerably shorter residence time and less 
negative redox status (Table 6.3). The size of the microbial effect upon As bioaccessibility after 
the 4 hour incubation was smaller than typically observed in the Colon SHIME, ranging between 
5 and 11%. These microbially-mediated increases in Ileum SHIME As bioaccessibility were not 
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 consistently observed when residence times were reduced to three hours or extended to five 
hours (Figure 6.1). This suggests that any microbial effects upon arsenic bioaccessibility under 
small intestinal conditions are transient. These results also indicate that BGS 102 is a better test 
material with which to evaluate microbial effects on As bioavailability. However, this soil has a 
relatively low As concentration thus impeding its use in an in vivo swine dosing trial. Therefore, 
the in vivo work described herein used the overburden test material from Mount Nansen, YK 
since this test material contains nearly 20-fold greater As concentrations and also shows a 
microbial effect (2.9-fold increase) on As bioaccessibility under simulated colon conditions.  
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Figure 6.1 Mean percent As bioaccessibility (± standard error) from three Hoboken soils 
(H5, H18, H50; n=3) following sample extraction in the Ileum stage of the Simulator of the 
Human Intestinal Microbial Ecosystem with (i.e., Active) and without (i.e., Sterile) microbial 
activity. When incubation time was 4 hours, ileal microbial activity increased (Holm-Sidak Test) 
As bioaccessibility for Hoboken soils H5 (P<0.001), H18 (P=0.001), and H50 (P=0.004). 
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 Table 6.3 The residence time and redox status of the Ileum and Colon stages of the 
Simulator of the Human Intestinal Microbial Ecosystem digests of the standard reference soil 
BGS 102. Values in parentheses represent the standard error of the mean. 
GI Stage Redox (mV) Residence Time (hr) 
Ileum SHIME -30.7 (3.2) 4 
Colon SHIME -305.0 (6.2) 18 
 
The GI microbial community of 3 of the 4 juvenile swine (p15, p18, and p13) treated with 
oral antibiotics (AB2-TM1) clustered separately from the microbial communities of swine not 
treated with antibiotics (AB0-TM1) (Figure 6.2). There was, however, considerable inter-
individual variation in the DGGE banding-patterns of the GI microbial communities in the swine 
proximal colon. For example, there was no more than 50% overlap in the banding-patterns of the 
oral-antibiotic treated swine. Furthermore, the banding-patterns of the microbial communities of 
untreated swine diverged as much as 40%. 
 
Figure 6.2 Pearson correlation cluster analysis of Denaturing Gradient Gel Electrophoresis 
results demonstrates that oral antibiotic treatment (neomycin and metronidazole) alters the 
normal microbial community of the juvenile swine proximal colon. The arsenic/antibiotic 
treatments of each lane is also noted: AB0-CON (neither antibiotic nor arsenic), AB2-TM1 (both 
arsenic and antibiotic), and AB0-TM1 (arsenic but not antibiotic).   
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 The urinary As excretion for the first collection period was significantly lower than the 
second (p=0.00433) and third (p=0.0149) urine collection periods. This indicates that urinary As 
excretion had not reached steady state until the 10th day of As exposure (i.e., D10). The urinary 
As excretion of swine and the absolute bioavailability of arsenic in the test material were 
equivalent (Holm-Sidak, P=0.930) in AB2-TM1 (i.e., arsenic + antibiotics) and AB0-TM1 (i.e., 
arsenic - antibiotics) (Table 6.4 & Table 6.5). Furthermore, the urinary As excretion of the p19 
(AB2-TM1), whose GI microbial community clustered with AB0-TM1 animals (Figure 6.2), was 
equivalent to the other animals in AB2-TM1. These observations support the conclusion that 
antibiotic-treatment induced changes in the GI microbial community did not affect the arsenic 
bioavailability for the Yukon mine overburden TM1. According to ethical guidelines calling for 
the reduction of animal use in toxicological research, the positive control (e.g., sodium arsenate) 
dosing group was dropped from the experimental design once it became apparent that antibiotic 
treatment did not alter urinary arsenic excretion. Including the positive control treatment groups, 
required for the calculation of RBAAs, would have doubled the number of animals euthanized 
while not augmenting our ability to test the primary hypothesis of the study (i.e., colon 
bioaccessibility is toxicologically relevant). Consequentially, the authors decided that proceeding 
with the positive control treatment groups was contrary to the three R’s of animal research and, 
thus, inappropriate for this study. Therefore, the RBAAs of TM1 cannot be calculated at this time. 
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 Table 6.4 The effect of antibiotic (neomycin and metronidazole) co-administration on the 
urinary As excretion (± standard error) of swine orally exposed to As from the overburden of an 
abandoned gold and silver mine. 
Urinary Arsenic Excretion (µg/48 hr) Treatment 
Group Description Coll Period #1 D7-D8 
Coll Period #2 
D10-D11 
Coll Period #3 
D13-14 
AB0-CON -Antibiotics 
-Arsenic 
325 
(16) 
368 
(18) 
417 
(11) 
AB0-TM1 -Antibiotics 
+Arsenic 
1457 
(98) 
1732 
(28) 
1673 
(95) 
AB2-TM1 +Antibiotics 
+Arsenic 
1282 
(225) 
1865 
(161) 
1743 
(71) 
 
Table 6.5 The effect of antibiotic (neomycin and metronidazole) co-administration on the 
arsenic absolute bioavailability (± standard error) of the overburden of an abandoned gold and 
silver mine following the oral exposure of swine. 
Arsenic Absolute Bioavailability (%) Treatment 
Group Description Coll Period #1 D7-D8 
Coll Period #2 
D10-D11 
Coll Period #3 
D13-14 
AB0-TM1 -Antibiotics 
+Arsenic 
12.1  
(0.9) 
14.2 
(0.3) 
13.2 
(1.0) 
AB2-TM1 +Antibiotics 
+Arsenic 
10.2 
(2.1) 
15.6 
(1.7) 
13.9 
(0.8) 
 
6.4 Discussion 
The in vitro SHIME results described herein demonstrate that As bioaccessibility is typically 
substantially less than the 100% assumed during PQRA. This research finding is in agreement 
with numerous articles describing the calculation of soil As bioaccessibility for human health 
risk assessment (Carrizales 2006; Hamel 1998; Ljung 2007; Navarro 2006; Oomen 2002; 
Pouschat 2006; Rodriguez 1999). Arsenic enrichment in the <100 µm fraction of H5 (5%), H18 
(29%) and H50 (140%) were considerably lower than those reported for the adhered fraction of 
sandy brownfield soils (Siciliano 2009) and the <90-µm fraction of a sandy soil collected near a 
Copper Chromium Arsenate (CCA)-treated utility pole (Girouard 2009). The effect of particle 
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 size fraction on soil As concentration was inconsistent between soils, perhaps reflecting 
differences in inorganic mineral (e.g., carbonate) surfaces between soil samples. Percent As 
bioaccessibility is often negatively correlated with soil As concentration due to thermodynamic 
or kinetic constraints on dissolution (Laird 2010). In contrast, the percent As bioaccessibility of 
the <100 µm fraction of H50 was substantially greater than that of the other Hoboken soils even 
though it possessed the greatest As concentration. These observations emphasize the importance 
of measuring the total As concentration and percent bioaccessibility from several size fractions 
on a site-specific basis when characterizing human exposure to soil contaminants (Girouard 
2009).  
Microbially-mediated increases in As bioaccessibility are likely of greatest toxicological 
relevance in the human small intestine since this organ is thought to be responsible for the 
majority of As uptake. However, the magnitude of the microbial effect upon soil As 
bioaccessibility in the Ileum SHIME (5-11%) was substantially lower than previously reported in 
the Colon SHIME (2 to 3-fold). Furthermore, the transient nature of the Ileum SHIME microbial 
effect on As bioaccessibility suggests that small intestinal GI microbial activity plays a 
negligible role in As toxicokinetics.   
In lieu of performing costly gnotobiotic research (Stuyven 2010), which requires experimental 
subjects to be born via cesarean section and subsequently housed in sterile environments, in vivo 
antibiotic and prebiotic co-administration studies have successfully been used to illustrate the 
role of GI microbial activity on the toxicokinetics of ingested contaminants (Rowland 1980; 
Rowland 1978). In one of these studies, the GI microbial community was eliminated within three 
days of oral antibiotic treatment (Rowland 1980). In contrast, the oral antibiotic treatment (at 
twice the therapeutic dosage of two antibiotics) described in this manuscript altered the 
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 composition of the GI microbial community but certainly did not eliminate it. Despite this, it is 
reasonable to assume that the structural changes observed in the GI microbial community 
(Figure 6.1) were relevant to As toxicokinetics since metronidazole targets anaerobic bacteria 
likely responsible for alterations in As bioaccessibility (Lofmark 2010). 
Since the majority of bioavailable As is rapidly metabolized and excreted in the urine, urinary 
As excretion is directly proportional to RBAAs (Casteel 2001). Consequentially, assuming that 
antibiotic treatment did not affect the metabolism, distribution, or excretion of As, differences 
between the urinary As excretion in treatment groups AB2-TM1 and AB0-TM1 would indicate 
that GI microbes affect RBAAs. However, the urinary As excretion of swine orally exposed to 
TM1 was identical with and without antibiotic co-administration (Table 6.4). Since in vitro 
results showed GI microbial activity to cause a 2.9-fold increase in the As bioaccessibility of 
TM1, the in vivo results described herein suggest that microbes do not affect As RBA even when 
they alter bioaccessibility. Of course, these results may prove to be specific to TM1 since only 
one soil was included in the experimental design. It should be noted that urinary As excretion 
underestimates As absorption since it does not account for As that is excreted in feces via the 
bile or deposited in other tissues (e.g., skin, hair, liver, kidney). Therefore, the interpretation of 
the results are somewhat impeded by the study design which prevented the calculation of the 
RBAAs of TM1. In addition, the experimental design of the in vivo swine study did not directly 
evaluate whether GI microorganisms altered the speciation of ingested As (e.g., via the formation 
of the highly toxic AsH3 gas in the colon). 
This research provides the strongest evidence to date indicating that GI microbial activity is of 
limited relevance to the calculation of soil As bioaccessibility in human health risk assessment. 
This conclusion, is in agreement with inter-laboratory comparisons that demonstrated that the As 
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 bioaccessibility of standard reference soils and the Yukon overburden as measured using PBET 
or SBET (without microbes) is equivalent to that of the SHIME (with microbes) (Laird 2009). 
This indicates that in vitro GI models that neglect to include a microbially active intestinal stage 
do not necessarily systemically underestimate the health risks posed by soil arsenic 
contamination. Therefore in vitro GI models that do not include microbial activity (e.g., PBET) 
may prove more efficient than the SHIME for the calculation of As bioaccessibility since such 
models are typically simpler and less expensive. These results, however, may prove specific to 
the small number of soils used in the in vitro and in vivo experiments described in this 
manuscript. In addition, it is not immediately apparent whether bioaccessibility estimates 
garnered from in vitro models that do not include microbial activity adequately reflect the health 
risks realized by the biotransformation of inorganic arsenic to more toxic forms (trivalent 
methylated species or AsH3 gas). Therefore, further work will be necessary before it is possible 
to discount the importance of GI microorganisms for the calculation of As bioaccessibility and 
bioavailability. 
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 7 PREDICTING METAL BIOACCESSIBILITY ACCORDING TO LABILITY VIA 
WATER EXCHANGE RATE CONSTANTS 
7.1 Introduction 
Risk assessors use gastrointestinal (GI) models for the calculation of in vitro bioaccessibility 
to estimate the percentage of an ingested contaminant likely to be solubilized into GI fluids 
(Ruby 1999). In contrast, the oral bioavailability of a contaminant, estimated via an animal 
dosing trial, refers to the percentage of an ingested contaminant that is absorbed across the GI 
epithelium and reaches systemic circulation (Basta 2007). Since dissolution into GI fluids is a 
requisite precursor for the intestinal absorption of metal contaminants, bioaccessibility is often a 
conservative predictor of oral bioavailability (Oomen 2003). Thus, incorporating bioaccessibility 
and bioavailability into exposure assessments enables risk assessors to account for limitations on 
the release and subsequent absorption of contaminants due to the accidental ingestion of 
contaminated particles (Roussel 2010).  
The development of in vitro GI models for the calculation of metal bioaccessibility has 
focused upon single elements most likely to pose health risks when at elevated soil 
concentrations. Thus, in vitro bioaccessibility of contaminated soils was first investigated for 
lead (Ruby 1993)(Ruby 1993), then for arsenic (Hamel 1999; Ruby 1996), and more recently for 
several other metals (Lamb 2009; Ljung 2007; Rasmussen 2008; Roussel 2010). For each of lead 
and arsenic, a common strategy requiring years of research was employed before bioaccessibility 
measurements were widely adopted into risk assessment. First, investigators examined which GI 
model parameters (e.g., pH, incubation time, LS ratio, microbial activity) affected metal release 
into simulated gastric and/or intestinal fluids (Drexler 2007; Hamel 1999; Laird 2007). 
Subsequently, investigators selected physiologically relevant GI model parameters that 
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 reproducibly maximized bioaccessibility of the metal and attempted to validate their model 
according to its correlation with in vivo bioavailability (Casteel 2001; Rodriguez 1999). 
Multi-contaminant approaches to the evaluation of bioaccessibility may streamline the 
development of in vitro GI models by reducing the need for the repetition of each of these 
procedures for all metals regulated via Canadian Council of Ministers of the Environment Soil 
Quality Guidelines (CCME SQG) (CCME 2007). It may prove advantageous to group metals 
and metalloids according to their fundamental chemical properties (e.g., ionic charge, ionic or 
hydrated radius, electronegativity, absolute hardness). Thereafter, in vitro GI model parameters 
may be extended and applied to soils contaminated with metals and metalloids with similar 
chemical properties. Additionally, establishing the role of fundamental chemical properties in 
determining the release of metals from soils into GI fluids may assist in the development of a 
predictive model for in vitro bioaccessibility.   
The primary objective of the research described in this manuscript was to evaluate the 
bioaccessibility of numerous metals from bulk soils collected in an urban Arctic brownfield in 
Iqaluit, NV. The Iqaluit soil samples were selected for this research since they not only possess 
elevated soil concentrations of several metal contaminants, but also their soil properties were 
previously established (Siciliano 2009). We examined differences in the bioaccessibility between 
metals and assessed the correlation between bioaccessibility and chemical properties to 
determine which chemical characteristics may prove useful in the prediction of metal 
bioaccessibility. 
7.2 Materials and Methods 
7.2.1 Soil collection 
In July 2007 approximately 200 soil samples were collected into 250-mL glass amber jars 
from the surface (10 cm) and sub-surface (50-100 cm) of an urban brownfield located in a 
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 residential neighborhood of Iqaluit, NV. Soil samples from the brownfield, in addition to soil 
blanks and soil spikes, were shipped via air cargo from Iqaluit to Saskatoon. Upon arrival in 
Saskatoon, the sample jars were transferred to a freezer where they were stored at -20°C until 
subsequent analysis. Metal, total petroleum hydrocarbons, and polycyclic aromatic hydrocarbon 
concentrations and bioaccessibility were measured from the bulk soil (<250 µm) to construct a 
contaminant map of the area. Nineteen of the 200 collected soil samples were selected for the 
research described in this manuscript. Metal enrichment in addition to soil properties of the bulk 
and adhered (i.e., particles that adhered to human hands) fractions of Iqaluit soils (Table 7.1) 
were previously described (Siciliano 2009). 
Table 7.1 Select properties of soils collected from an urban Arctic brownfield in Iqaluit, 
Nunavut. 
 
>2mm 
Gravel 
(%) 
<2 mm 
Total 
Organic 
Carbon 
(%) 
Bulk Total 
Organic 
Carbon 
(%) 
Adhered 
Total 
Organic 
Carbon 
(%) 
Bulk 
Average 
Particle 
Size  
(µm) 
Adhered 
Average 
Particle 
Size  
(µm) 
Mass Per 
Hand-
Washing 
(g) 
Soil 
pH 
Mean 
(CV%) 
16.8 
(27.7) 
0.5 
(70.5) 
0.4 
(71.2) 
0.7 
(38.1) 
486 
(52.0) 
164 
(75.7) 
0.4 
(42.0) 
8.0 
(7.4) 
Min 3.7 0.2 0.2 0.4 33.0 26.1 0.2 6.6 
Max 26.7 1.6 1.3 1.2 924 480 0.9 8.7 
 
7.2.2 Measurement of soil metal concentration 
Each of the 19 bulk soil samples were microwave digested before being syringe filtered (0.45 
µm) and diluted to 2% HNO3 to facilitate a multi-element scan of 24 elements using Inductively 
Coupled Plasma-Mass Spectrometry (ICP-MS). The total soil concentrations for beryllium (Be), 
aluminum (Al), titanium (Ti), vanadium (V), chromium (Cr), manganese (Mn), iron (Fe), cobalt 
(Co), nickel (Ni), copper (Cu), zinc (Zn), arsenic (As), selenium (Se), strontium (Sr), 
molybdenum (Mo), silver (Ag), cadmium (Cd), tin (Sn), antimony (Sb), barium (Ba), mercury 
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 (Hg), thallium (Tl), lead (Pb), and uranium (U) from each of the 19 bulk soil samples were 
measured using ICP-MS (Table 7.2). The authors note that both As and Sb are more accurately 
described as metalloids; however, they have been labeled as metals for the remainder of the 
manuscript for the sake of brevity. 
Table 7.2 Limit of Detection (LODsoil) and total metal concentrations of soils collected from 
Iqaluit, NV.  
Metal 
Soil Concentration Range 
(mg kg-1) 
LODsoil  
(mg kg-1) 
Be 0.9 – 1.4 0.3 
Al 32000 – 63000 18 
Ti 2900 – 6700 17 
V 43 – 95 0.06 
Cr 30 – 62 3.5 
Mn 520 – 940 0.6 
Fe 29000 – 58000 27 
Co 12 – 19 0.05 
Ni 9.1 – 16.0 0.6 
Cu 6.4 – 27 0.6 
Zn 64- 1000 3.1 
As 1.0 – 2.2 0.8 
Se < LOD 0.03 
Sr 160 – 280 0.23 
Mo 0.8 – 5.6 0.05 
Ag < LOD – 1.2 0.10 
Cd 1.3 – 8.5 0.01 
Sn 0.7 – 11 0.03 
Sb 0.02 – 0.37 0.01 
Ba 890 – 1200 0.26 
Hg 0.12 – 0.51 0.06 
Tl 0.29 – 0.49 0.002 
Pb 17 – 45 0.08 
U 0.44 – 1.4 0.02 
 
The microwave digestion required the addition of 100 mg of soil into Teflon-coated tubes 
(Xpress, CEM). Subsequently, 3 mL of HNO3 (16 M, EMD, Omnitrace) and 0.5 mL of H202 
(EMD) were added to each tube. After the H2O2-mediated reaction subsided, 1.5 mL of 40% HF 
(EMD) was added to each tube. The tubes were then capped, sealed and placed in a microwave 
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 (MARS-5, CEM) in which the samples were digested at 1600 W (100%) power at 200°C for 3 
hours. This heating cycle was repeated until all of the soil particles in each of the tubes were 
completely digested. Boric acid (EMD, 5%, 12 mL) was then added to each of the tubes, which 
were then returned to the microwave for 30 minutes to deactivate the HF. The acid digests were 
subsequently syringe filtered and diluted to 2% HNO3 for metal quantification.  
7.2.3 Static Simulator of the Human Intestinal Microbial Ecosystem 
As described in Section 3.2.3, metal bioaccessibility was measured for each of the 24 elements 
listed above using the stomach and duodenum stages of the Simulator of the Human Intestinal 
Microbial Ecosystem or SHIME (Laird 2010). In brief, 900 mg of each of the 19 Iqaluit soils 
was added to labeled glass serum bottles for both the stomach (1 bottle per soil sample) and 
duodenum (1 bottle per soil sample) stages of the SHIME. Dilute HCl (EMD, Omnitrace) in 
milli-Q H2O (36 mL, pH 1.4) was added to the serum bottles and the pH of the soil suspension 
was then adjusted to pH 1.5±0.1 via dropwise addition of 0.5 M NaOH/HCl. The samples were 
then incubated at 37°C for 2 hours with horizontal shaking (70 rpm). Next, the bioaccessible 
fraction was separated from each Stomach SHIME sample whereas 18 mL of pancreatic solution 
(12.5 g L-1 sodium bicarbonate (EMD), 6 g L-1 Oxgall (BD DifcoTM), and 0.9 g L-1 pancreatin 
(Sigma)) was added to each Duodenum SHIME sample. Subsequently, the pH of the Duodenum 
SHIME samples was adjusted to 6.5±0.1. The Duodenum SHIME samples were then returned to 
the incubator/shaker for an additional 2 hours of shaking. After the Duodenum SHIME 
incubation, the bioaccessible fraction was separated for each of the samples. The separation of 
the bioaccessible fractions for the Stomach SHIME and Duodenum SHIME utilized syringe 
filtration (0.45 µm Whatman GMF). The bioaccessible (i.e., syringe filtered) SHIME fluid was 
then acidified (2% HNO3) and the aqueous concentration of each of the 24 metals listed above 
was measured using ICP-MS. Percent bioaccessibility (Equation 7.1) of each metal was 
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 calculated by expressing the micrograms of blank corrected bioaccessible metal as a percentage 
of the total amount of the metal contained with the 900 mg soil sample: 
 100%
g Sample Soilin  Present Metal
g   Solutionin  Released Metal(%)bility Bioaccessi ×=
)(
)(
μ
μ   (Eqn 7.1) 
7.2.4 Quality Assurance - Quality Control 
Percent bioaccessibility for each metal in each soil was only included for samples containing 
detectable concentrations of that metal in both the soil sample and the bioaccessible SHIME 
liquid fraction. Notably, soil and simulated GI fluid concentrations of selenium were below 
detection limits in each sample; therefore, selenium was discarded from further analysis. Two of 
the 19 Iqaluit soil samples were extracted in duplicate in the Stomach SHIME to evaluate the 
repeatability of the results. The median percent deviation of duplicates for metal bioaccessibility 
was 10.5%.  
7.2.5 Statistical analysis 
Median absolute deviation (MAD), which is defined as the median of the absolute deviations 
about the median of a dataset (Teng 2010), for metal bioaccessibility was calculated using the 
equation MAD = mediani (|Xi - medianj(Xj)|). The 90th percentile of metal bioaccessibility was 
determined using the cumulative frequency distribution calculated according to the Parkhurst 
Equation (P = (100 x i/(n+1)) where P is the probability of the ith the rank in a distribution of n 
values (Parkhurst 1996). Correlations between metal bioaccessibility and fundamental chemical 
properties were evaluated using Spearman Rank Order (SigmaStat v3.1) and were defined as 
significant when p<0.05. Stomach SHIME and Duodenum SHIME isotherms (Laird 2010) were 
created for each metal, excluding non-detects, by plotting the relationship between the metal 
concentration in the soil (Y-axis) and the metal concentration in the bioaccessible fraction of the 
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 SHIME liquid (X-axis). Isotherm linearity was assessed using linear regression (ANOVA, 
p<0.05) after checking normality and homogeneity of variance assumptions (SigmaStat v3.1). 
7.3 Results 
Median in vitro bioaccessibility of was highly variable between metals, spanning three orders 
of magnitude (Stomach SHIME: < 1% and 41%; Duodenum SHIME: <1% - 63%). The 90th 
centile for metal percent bioaccessibility was 74% in the Stomach SHIME and 82% in the 
Duodenum SHIME, thereby providing further evidence that assuming 100% GI absorption is 
overprotective (Figure 7.1). Al, Ti, and Cr, each thought to be poorly absorbed across the GI 
epithelium (ATSDR 2008; Calabrese 1996), demonstrated negligible release into simulated GI 
fluids. However, it is notable that the bioaccessibility of these poorly absorbed metals is similar 
to the bioaccessibility of Tl, which is readily absorbed following oral exposure (ATSDR 1992). 
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Figure 7.1 Median percent bioaccessibility (±standard error) of 23 metals extracted from 19 
soils collected from a brownfield in Iqlauit, NV using the gastric and duodenum stages of the 
Simulator of the Human Intestinal Microbial Ecosystem. 
 
In vitro metal bioaccessibility was occasionally correlated with the limited set of soil 
properties included for the purposes of this study (e.g., soil pH, particle size, total organic carbon 
(TOC), and > 2mm percent gravel) (Table 7.3). Bioaccessibility of Cr and Sr increased with 
increasing soil pH in the Stomach SHIME and/or Duodenum SHIME. In addition, Al, V, and Fe 
bioaccessibility increased with increasing Mass Per Handwashing (MPHW; i.e., the amount of 
soil that adhered to the skin of human adult hands) in the Stomach SHIME whereas Cd 
bioaccessibility decreased with increasing MPHW in the Duodenum SHIME. Correlations 
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 between particle size and bioaccessibility were more commonly observed in the Duodenum 
SHIME than in the Stomach SHIME. For example, smaller particle sizes (bulk soils) were 
associated with higher metal bioaccessibility for Ni and Tl whereas smaller particles 
demonstrated lower metal bioaccessibility for Cr and Cd. In contrast, no correlations (p>0.05) 
were observed between metal bioaccessibility and bulk soil particle size in the Stomach SHIME. 
Few inter-correlations were observed between soil properties and these correlations were most 
apparent between the various measures of TOC and pH. For example, TOC for the < 2 mm 
fraction was correlated with the TOC adhered (R=0.779; p<0.001) and bulk (R=0.993; p<0.001) 
fraction of the Iqaluit soils. Concordantly, the TOC for the adhered fraction correlated with the 
TOC of the bulk soils (R=0.779; p<0.001). Additionally, the TOC of the adhered soil was 
negatively correlated with soil pH (R=-0.825; p<0.001). This relationship is supported by the 
fact that soil organic matter is typically composed of weak acids (carboxyl & quinone functional 
groups (Sparks 2003). 
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 Table 7.3 Correlation (Spearman Rank Order) between metal bioaccessibility in the 
Stomach and Duodenum stages of the Simulator of the Human Intestinal Microbial Ecosystem 
(SHIME) and soil properties. P-values < 0.05, <0.01, and 0.001 are denoted by *, **, and ***, 
respectively. 
Soil Properties Stomach SHIME Duodenum SHIME 
pH Cr (R=0.686)** Sr (R=0.800)*** Sr (R=0.721)** 
Mass Per 
Hand-washing 
Al (R=0.529)* 
V (R=0.582)* 
Fe (R=0.614)* 
Cd (R=-0.536)* 
Average 
Adhered Particle Size Al (R=-0.604)* V (R=0.532)* 
Average Bulk Particle 
Size 
No Correlations 
Observed 
Cr (R=0.529)* 
Ni (R=-0.786)* 
Cd (R=0.664)** 
Tl (R=-0.783)** 
Adhered Total Organic 
Carbon (%) Sr (R=-0.661)** 
Ni (R=-0.690)* 
Sr (R=-0.650)** 
Mo (R=-0.611)* 
Tl (R=0.833)** 
Bulk Total Organic 
Carbon (%) As (R=0.648)* 
Ni (R=-0.810)** 
Tl (R=0.683)* 
< 2 mm Total Organic 
Carbon (%) As (R=0.661)* Ni (R=-0.833)** 
>2 mm Gravel (%) Be (R=0.706)** Cd (R=0.857)*** No Correlations Observed 
 
No significant correlations (Spearman Rank Order) were observed between metal 
bioaccessibility and (a) electronegativity (R=0.299; p=0.162), (b) covalent radius (R=-0.177; 
p=0.600), or (c) enrichment (R=-0.0791; p=0.716) (Figure 7.2). Similarly, when solubility and 
adsorption stability constants were compiled from Mineql 4.5 and several texts (Irving 1953; 
McBride 2000; Stumm 1996), no significant correlations were observed. For example, metal 
bioaccessibility under simulated stomach conditions was independent of stability constants for 
metal adsorption on oxides (R=-0.190; p=0.619) and carbonates (R=-0.236; p=0.490) (Table 
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 7.4). Similarly, metal bioaccessibility was independent of the solubilities of metal carbonates, 
sulfides, and hydroxides (Table 7.4). It must be noted that each set of metal stability and 
solubility constants was obtained from a single source.  
Table 7.4 Metal bioaccessibility under simulated stomach and small intestinal conditions 
was independent (Spearman Rank Correlation; p>0.05) of metal stability and solubility constant 
obtained from Mineql 4.5 and several texts (Irving 1953; McBride 2000; Stumm 1996). Each set 
of metal stability and solubility constants was obtained from a single source. 
 Bioaccessibility Solubility 
Me 
Stom 
(%) 
Duo 
(%) 
Stom 
(mM) 
Duo 
(mM) 
MeCO3 
(log k) 
Metal 
Ligand 
(log k) 
MeS 
(log k)
Me(OH)3 
(log k) 
Mn 8.8 2.7 2.1e-2 3.4e-1 -10.7 3.2 -14.8  
Fe 0.7 0.03 1.3e-1 1.8e-1 -10.5  -26.9  
Co 3.8 2.0 2.5e-4 5.6e-3 -12.9 4.4 -22.2 -0.46 
Ni 4.5 1.6 2.0e-4 4.0e-3 -8.2 4.8 -20.5 0.37 
Cu 16.4 17.7 7.2e-4 3.4e-2 -9.9 6.1 -36.1 2.89 
Zn 40.6 28.3 1.2e-2 3.4 -10.9 4.5 -24.7 0.99 
Cd 1.3 5.3 4.9e-6 1.7e-3 -11.3  -27.8 0.47 
Sr 1.2 3.0 7.6e-4 1.1e-1 -9.0 2.8  5.01 
Pb 9.3 0.4 2.4e-4 1.3e-3 -13.1  -27.5 4.65 
Ba 3.6 32.0 7.7e-3 6.3 -8.3 2.3  5.46 
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Figure 7.2 No relationships were observed between bioaccessibility (Stomach Stage: Open 
Symbols; Duodenum Stage: Closed Symbols) and electronegativity, covalent radius, or 
enrichment. Each point represents the bioaccessibility of a single metal. 
 
Instead, differences between the median bioaccessibility of metals were explained by the 
linearity of the soil-solution isotherms. Metals with isotherms that demonstrated a positive 
(p<0.05) linear slope were more bioaccessible than metals a non-significant slope (Figure 7.3). 
Although it is possible for non-linear isotherms to describe systems that reach steady state 
(Sparks 2003), the absence of straight-line isotherms may indicate that the dissolution processes 
(eg. cation exchange) failed to reach steady state for those metals without straight-line isotherms. 
In other words, poorly bioaccessible metals may not have reached steady state and hence may 
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 have been impeded by kinetic constraints on dissolution. Indeed, metal lability, as predicted from 
water exchange rates (kH20ex) (Richens 1997; Taube 1952), was positively correlated with the 
bioaccessibility of V, Fe, Ni, Co, Mn, Zn, Cu, Al, Be, & U in the Stomach SHIME and the 
bioaccessibility of Fe, Ni, Co, Mn, Zn, Cu, Be, U, Cd, & Ba in the Duodenum SHIME (Figure 
7.4). Including soil properties with kH20ex did not improve the prediction of metal bioaccessibility 
according to multiple linear regression (stepwise forward). Similarly, previously published 
bioaccessibility values increased with increasing kH20ex for Al, Ni, Zn, and Cu under simulated 
stomach conditions (Figure 7.5). However, in contrast to the results for the Iqaluit soils, metal 
bioaccessibility was independent of kH20ex under simulated duodenal conditions (Figure 7.6). 
 
 
Figure 7.3 Median percent bioaccessibility (± Median Absolute Deviation) of metals with 
linear isotherms was higher than for those metals without a linear isotherm in the Stomach and 
Duodenum stages of the Simulator of the Human Intestinal Microbial Ecosystem. Significant 
differences in bioaccessibility (denoted with an asterisk, p<0.05) were defined using the Kruskal-
Wallis One-Way ANOVA test. 
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Figure 7.4 Effect of water exchange rate (kH20ex) on median metal bioaccessibility in the 
Stomach and Duodenum stages of the Simulator of the Human Intestinal Microbial Ecosystem. 
Each data point represents the bioaccessibility of a metal cation either regulated (CCME Reg) or 
not-regulated (Non-Reg) by the Canadian Council of Ministers of Environment. 
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Figure 7.5 A positive relationship was observed between water exchange rate (kH2Oex) and 
the bioaccessibility of metals from a diverse range of contaminated soils described in previous 
peer-reviewed manuscripts. Bioaccessibility results represent those calculated under simulated 
stomach conditions. 
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Figure 7.6 No relationship was observed between water exchange rate (kH2Oex) and the 
previously published metal bioaccessibility values under simulated duodenum conditions. The 
bioaccessibility data was obtained from previously published peer-reviewed manuscripts 
describing a diverse range of contaminated sites distributed across the globe. 
 
7.4 Discussion 
In the dried soils, metals are present either as discrete insoluble phases (carbonates, oxides, 
and hydroxides) or bound in either ion exchange on the negative surfaces of soil organic matter 
and inorganic minerals (CEC or cation exchange capacity) or potentially as inner-sphere 
complexes (Figure 7.7).  When the soil is placed in the Stomach SHIME, it is forced into 
equilibrium with 0.1M HCl.  This results in dissolution of some metal precipitates, proton 
saturation of soil surfaces, and reactive surface functional groups becoming positively charged 
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 (as Al-OH2+) or neutral (R-OH or Si-OH).  At this pH, CEC decreases markedly and soils 
develop anion exchange capacity (AEC) instead and Cl- will displace cations at the surface.  
Some metals are known to form ternary complexes with mineral surfaces and Cl-, and these 
metals will preferentially be retained under these conditions (Figure 7.7). Metals may display 
lower-than-expected solubilities if they are present in phases (e.g. oxides or as substituents in 
clay minerals) that don’t fully dissolve over the reaction time in the stomach reactor.   
 
Figure 7.7 Schematic of surface site and solution changes as soils move through the 
Simulator of the Human Intestinal Microbial Ecosystem.  Note that cations in general are shown 
as Me for sake of brevity. DOM represents dissolved organic matter, CEC represents cation 
exchange capacity, and AEC represents anion exchange capacity. Ternary metal complexes are 
denoted by R-OH2+-Cl-Me. 
In the small intestine, the chemistry drastically changes again as the system is buffered to pH 
6.5 using 0.5 M NaHCO3.  Under these solution conditions, the surface may again becomes 
negatively charged and CEC increases according to the point of zero charge of the soil 
components (Table 7.5).  Cations (and specifically Na+ due to its concentration) will displace Cl- 
at the soil surface, and soluble Me-carbonate complexes and metal carbonate precipitates may 
form.  One side effect of Na saturation of soils is dispersion of soil particles.  This will increase 
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 the bioaccessibility of metals with small hydrated radii, as they previously may have been found 
in internal micropores of soil aggregates which become exposed to the soil solution in Na 
solutions. 
Table 7.5 Point of zero charge of soil components (reproduced with modifications from 
Sparks 2003). 
Soil Component Point of Zero Charge 
Fe(OH)3 8.5 
Al(OH)3 5.0 
Fe2O3 6.7 
SiO2 2.0 
Soil Organic Matter ~ 3 
 
In the Stomach SHIME, due in part to the considerable variation of metal bioaccessibility 
between different test materials, the percent bioaccessibilities of Al, Cr, Mn, Zn, As, Sb, Ba, & 
Hg in the Iqaluit soils were similar (eg. within 10%) of the bioaccessibility of metals reported in 
(a) soils contaminated with marine paints (Turner 2009), (b) tundra soils (Shock 2007), (c) Basic 
Oxygen Furnace Slag (Proctor 2002), (d) urban soils collected in Torino (Madrid 2008) and 
Ottawa (Rasmussen 2008), (e) chat from Tar Creek Superfund Site (Schaider 2007), smelter 
impacted soils (Carrizales 2006), (f) mining waste effected soils (Denys 2008), and (g) a soil 
collected near a chlor-alkali plant in Eastern Canada (Welfringer 2009). However, the gastric 
bioaccessibilities of several other metals (e.g., Be, V, Ni, Cu, Cd, & Pb) in the Iqaluit soils were 
substantially lower than values reported in the literature (Bannon 2009; Hamel 1998; Oomen 
2002; Proctor 2002; Roussel 2010). This is also consistent with previous work that showed metal 
bioaccessibility measured using the SHIME is often lower than values generated using different 
in vitro models (Oomen 2002; Van de Wiele 2007). In the Duodenum SHIME, Iqaluit soil metal 
bioaccessibilities of Cu (Roussel 2010), Sb (Denys 2008), Hg (Barnett 2001), U (Frelon 2007), 
Al, Cr, and Sn (Turner 2009) were equivalent (eg. within 10%) to previously reported values.  
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 Previous research examining these same Iqaluit soils showed there to be a strong correlation 
between metal enrichment in the fine (i.e., <45 µm) fraction and adsorption stability constants 
onto mineral surfaces (Siciliano 2009). Consequentially, adsorption is likely an important 
mechanism by which metals are retained in these soils. Despite this, metal bioaccessibility was 
independent (R2 < 0.2) of stability constants for metal adsorption on oxides and carbonates. 
Similarly, metal bioaccessibility was independent (R2 < 0.2) of the (a) solubilities of metal 
carbonates, sulfides, and hydroxides and (b) stability constants of metal-ligands. However, the 
applicability of thermodynamic solubility and stability constants for metal bioaccessibility in the 
SHIME depends upon adsorptive and desorptive processes reaching steady state (Stumm 1970). 
Therefore, the failure of thermodynamic measures to reflect differences in metal bioaccessibility 
in the SHIME could be due to the failure of metal sorption to achieve steady state.  
One approach to estimating the effect of kinetics on metal bioaccessibility is to correlate them 
with metal lability via water exchange rates (kH2Oex). The process of water exchange is a simple 
substitution reaction in which a solvent molecule (e.g. H2O) in the ion solvation shell is replaced 
with another H2O molecule from the bulk solvent (Burgess 1999). More labile metal centers 
have higher rates of water exchange in solution, which in our system should be correlated with 
increasing release into solution and greater bioaccessibility. The strong log-linear relationship 
observed between kH20ex and metal bioaccessibility in the SHIME supports the hypothesis that 
dissolution kinetics are useful for the prediction of soil metal bioaccessibility in human health 
risk assessment. This result is consistent with previous work that demonstrated that As release 
from synthesized amorphous scorodite fails to reach steady state in the intestinal stages of the 
SHIME (Laird 2009). 
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 Water exchange rate was useful for the prediction of the metal (e.g., V, Ni, Zn, Cu, U, Cd, & 
Ba) bioaccessibility in the Stomach SHIME and/or Duodenum SHIME for 7 of the 13 metals 
regulated according to CCME SQG in Canada (CCME 2007). Additionally, kH2Oex was 
associated with the bioaccessibility of several metals which do not have a CCME SQG (e.g., Fe, 
Co, Mn, & Be). This indicates that kH20ex may serve as the foundation of a predictive model that 
facilitates risk assessors to estimate the bioaccessibility of select metals in human health risk 
assessment. However, it is crucial to remember that the results described in this manuscript are 
based upon the rather limited set of soils collected from the Iqaluit brownfield. Furthermore, a 
high in vitro bioaccessibility does not necessarily denote a high in vivo bioavailability. 
Therefore, these results must first be confirmed (in vitro and in vivo) for a wider set of soils with 
larger range of metal concentrations before it would be appropriate for this model to be broadly 
applied to ingestion exposure estimates for human health risk assessment.  
Water exchange rates are, however, not universally able to predict the bioaccessibility of all 
metals. For example, kH20ex over-predicts Pb bioaccessibility of the Iqaluit soils, likely due to the 
formation of ternary chloride complexes in the Stomach SHIME (Mineql+) and the precipitation 
of Pb carbonates in the Duodenum SHIME (Pokrovsky 2002). Similarly, CdCl complexes are 
also likely to form in the Stomach SHIME but not Duodenum SHIME which is consistent with 
Cd bioaccessibility being associated with its kH20ex in the Duodenum SHIME but not Stomach 
SHIME (Table 7.6).   
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 Table 7.6 Chloride complex speciation of metal cations in the Stomach stage of the 
Simulator of the Human Intestinal Microbial Ecosystem according to Mineql+ to evaluate 
whether or not the metal is likely to form ternary chloride complexes resulting in reduced 
bioaccessibility. Metal cations are denoted Me for the sake of brevity whereas metal preciptates 
are denoted Ppt.  
Percent of Metal in Form of: 
Metal 
Soil 
Concentration 
(mg kg-1) 
Solution 
Metal 
(mM) Me
2+ MeCl+ MeCl2 Ppt 
Fe-Me-Cl 
Ternary 
Complexes 
Ba2+ 1200 0.22 100 * * * * 
Cd2+ 8.5 1.9e-3 65 17 18 0 Yes 
Zn2+ 1000 0.38 93 7 0 0 No 
Pb2+ 45 5.4e-3 35 55 10 0 Yes 
Tl+ 0.49 6.0e-5 80 20 0 0 No 
 
The bioaccessibility of Tl is also over-predicted by its kH20ex; however, Tl-Cl ternary 
complexes are unlikely since the majority of bioaccessible Tl is the free metal ion (Mineql+). 
Instead, the bioaccessibility of Tl in the SHIME may be limited by its physical inaccessibility to 
solvation since the likely source of Tl in our samples are the interlayers of feldspars and micas 
(Siciliano 2009). It should also be noted that kH20ex cannot be used to predict the bioaccessibility 
of metals that predominately form oxyanions under the physiological conditions of the GI tract 
(e.g., As, Cr, Se) since little is known of kH20ex of anions (Burgess 1999). Despite this, uranium 
fit the relationship between bioaccessibility and kH2Oex in both the simulated stomach and small 
intestine whereas vanadium fit the relationship between bioaccessibility and kH2Oex in only the 
simulated stomach. This is surprising since both these elements could be, like As, Cr, and Se, 
present as oxyanions. However, vanadium could also be present as V2+ or V3+ since such 
vanadium cations substitute into aluminum oxides. Similarly, uranium, if present as U(VI), can 
also be present as an oxocation. Until further work is performed evaluating the speciation of 
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 vanadium and uranium in both the Iqaluit soils and simulated gastrointestinal fluids, the precise 
reason why uranium and vanadium appear to fit the relationship with kH2Oex will, unfortunately, 
remain unknown and the realm of speculation. 
Since metal bioaccessibility often varies with soil properties and mineralogy, it would be 
inappropriate to use a single bioaccessibility predicted by the relationship between kH20ex and 
bioaccessibility for all soils. Instead, as outlined in Equation 7.2, previously unknown 
bioaccessibilities (i.e. Stomach ABA and Duodenum ABA) of metal cations can be 
approximated using the bioaccessibility of another metal (i.e., ABAknown) in that same soil 
sample, the slope of the relationship between log kH20ex and log bioaccessibility, and the 
difference between the kH20ex of the known and unknown metals: 
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  (Eqn 7.2) 
We tested the accuracy of the model using previously published (Hansen 2007; Ljung 2007; 
Madrid 2008; Poggio 2009; Rasmussen 2008; Roussel 2010; Turner 2009) bioaccessibilities of 
Ni, Cu, Zn, and Al (Simulated Stomach) and Cd, Ni, Cu, Zn, and Ba (Simulated Duodenum). 
The model was effective in predicting metal bioaccessibility under simulated stomach conditions 
with an overall median residual of absolute metal bioaccessibility of 0.5% (Table 7.7). In 
contrast, the model was less effective under simulated duodenal conditions, often over-predicting 
metal bioaccessibility (overall median residual of absolute metal bioaccessibility = 8.0%). In 
conclusion, the concepts of metal lability and water exchange rates may provide risk assessors 
with a useful tool to predict the bioaccessibility of metal contaminants in soil. 
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Table 7.7 Residual (%) for predicted in vitro bioaccessibility (IVBA), calculated as 
IVBApredicted – IVBAactual, of metals under simulated stomach and duodenal conditions according 
to kH20ex model (Equation 7.2).  
 Simulated Stomach Conditions 
Known Metal Al  Cu   Zn 
Unknown Metal Zn Cu   Ni   Cu Ni 
Median Residual -10.7 -3.3   -1.8   +13.7 -0.5 
Min Residual NA NA   -8.7   +5.3 -0.5 
Max Residual NA NA   -1.1   +21.3 +4.5 
Reference 1 1   2, 3, 4   1, 2, 3, 4 2, 3, 4
 Simulated Duodenal Conditions 
Known Metal Cd Cu Zn Ni 
Unknown Metal Cu Zn Ba Ni Zn Ba Ba Cu Zn 
Median Residual +11.7 -4.4 +11.7 -8.1 +1.6 +18.2 +20.4 +102.9 +49.0 
Min Residual -7.6 NA NA -14.7 -1.1 NA NA NA NA 
Max Residual +31.0 NA NA -1.6 +4.2 NA NA NA NA 
Reference 1, 5 1 1 6, 7 1, 4 1 1 4 4 
(1) (Turner 2009) 
(2) (Rasmussen 2008) 
(3) (Madrid 2008) 
(4) (Poggio 2009) 
(5) (Roussel 2010) 
(6) (Ljung 2007) 
(7) (Hansen 2007) 
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 8 SUMMARY DISCUSSION, CONCLUSIONS, AND FUTURE WORK 
Risk assessment guidelines currently employed for contaminated sites use a default relative 
bioavailability (RBA) of 100% when estimating oral exposure (Health Canada 2004a). If RBA, 
as measured using in vivo animal experiments, differs from the RBA of the toxicological 
reference value (TRV) material, then the default assumption of 100% bioavailability is likely to 
overestimate health risk (Richardson 2006; Shock 2007). Such inaccuracies in exposure and risk 
assessments can thereby lead to the implementation of very costly yet unnecessary cleanup 
strategies. These decisions can divert resources from contaminated sites that pose legitimate 
threats to human health. The high cost (both time and financial) of in vivo animal experiments 
has provided incentive for the development of in vitro techniques that measure bioaccessibility 
(IVBA) (Ruby 1993). The three principal goals of this research project are (1) to evaluate the 
IVBA of arsenic (As) from soils and the IVBA of mercury (Hg) from traditional northern 
country foods, (2) to determine whether it is necessary to include a microbially active stage when 
measuring contaminant bioaccessibility of As and Hg, and (3) to ascertain what factors make 
some metal more bioaccessible than others. Fundamental research questions being addressed 
through these studies include: is the IVBA of ingested contaminants typically less than 100%? Is 
percent IVBA independent of the concentration of the contaminant in the exposure matrix? Does 
microbial activity affect metal IVBA and/or speciation? And if so, are these microbial effects 
relevant to estimates of ingestion exposure? Lastly, and perhaps most importantly, what chemical 
properties make some metals more bioaccessible than others? 
8.1 Principal Findings 
Arsenic IVBA from contaminated soils and Hg IVBA from traditional northern country foods 
were often substantially less than 100%, thus confirming the global hypothesis of this research 
project. For example, mean HgT IVBA from 16 country foods was 35% (Table 3.1). Similarly, 
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 the IVBA (under simulated small intestinal conditions) of As from mine tailings ranged between 
2 and 20% (Figure 4.1) whereas the IVBA of As from poorly crystalline scorodite ranged 
between 1 and 84% (Figure 5.1). Furthermore, the median bioaccessibility of metals collected 
from an urban Arctic brownfield was 2% (Figure 7.1). Each of these studies demonstrated that 
the IVBA of metals rarely approaches the default value of 100%. Therefore, higher-tier risk 
assessments (e.g., SSRAs) should include estimates of IVBA or RBA to better balance realism 
with precaution. This recommendation is in agreement with recommendations presented in D.J. 
Paustenbach’s (1989) seminal text: The Risk Assessment of Environmental and Human Health 
Hazards. In this text, Paustenbach (1989) cautioned risk assessors from over-zealously utilizing 
worst-case assumptions. For example, systematically selecting the 95th percentile of the 
distributions for each variable used in the calculation of ingestion exposure (e.g., CS, IRS, BW, 
AFGIT) compounds the level of confidence to 99.9994% (e.g., [1-(0.054)]=0.999994), far above 
the desired level of 95% (Paustenbach 1989).  
Arsenic IVBA is inversely related to test material As concentration for mine tailings (Figure 
4.1), scorodite (Figure 5.1), and arsenate (AsV) adsorbed on ferrihydrite (Figure 5.2). In 
contrast, no such relationship was observed for either Hg in traditional country foods (Table 3.1) 
or As in Hoboken soils (Table 6.2). Such inconsistency between and within contaminants of 
potential concern is in agreement with previous research. For example, contaminant IVBA 
occasionally decreased with increasing concentration (Beak 2006b; OME 2002; Richardson 
2006) whereas IVBA was independent of contaminant concentration for other studies (Barnett 
2001; Pouschat 2006; Ruby 1996). The inconsistency of these results is further complicated by 
the fact that such inverse relationships are potentially artifacts of the in vitro GI model 
procedures. Specifically, inverse relationships between IVBA and concentration may strictly be a 
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 function of inadequacies of the in vitro GI model methodologies. For example, the ratio of 
gastrointestinal (GI) fluid volume to soil mass (i.e., LS ratio) is commonly two orders-of-
magnitude lower in vitro than observed in vivo (Richardson 2006). This practice can result in soil 
contaminants (e.g. As, Ni, Pb) reaching their solubility limits, thus saturating simulated GI fluids 
(Hamel 1998) and underestimating the health risk posed by the contaminant (Richardson 2006). 
Additionally, contaminant IVBA can be limited by kinetic constraints on dissolution in vitro that 
are not present in vivo (Laird 2010). Alternatively, inverse relationships between IVBA and 
concentration may occasionally reflect in vivo toxicokinetic data (i.e., the inverse relationship is 
a real phenomena). In these cases, the dose for ingestion exposure (Eqn 2.3) does not linearly 
increase with increasing soil concentration. Consequentially, decreases in IVBA may negate the 
effect of increased soil concentration on ingestion exposure. Discerning whether an inverse 
relationship between IVBA and concentration is a true phenomenon or if it is an artifact of the in 
vitro model requires expert judgment and careful peer-review. The accuracy of human health risk 
assessments and the consequent appropriateness of remedial actions are contingent upon 
correctly identifying and explaining site specific relationships between IVBA and concentration.  
Gastrointestinal microbial activity decreased HgT IVBA from most of the studied northern 
country foods, but increased HgT IVBA from seal intestine and Arctic char flesh and did not 
alter HgT IVBA from narwhal skin (Figure 3.1). In contrast, GI microbial activity under 
simulated colon conditions increased As IVBA for the bulk and <38 µm fraction of mine tailings 
(Figure 4.2), synthesized scorodite (Figure 5.1), some loadings of AsV adsorbed ferrihydrite 
(Figure 5.2), an As contaminated ironstone soil (Laird 2009), an agricultural soil containing 
elevated As concentrations (Laird 2009), and an uncontaminated agricultural soil (Laird 2009). 
Since Dissimilatory Iron Reducing Prokaryotes (DIRPs) (Oremland 2005) are likely responsible 
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 for the mobilization of As from contaminated soils and soil-like particles (Figure 5.4 & Figure 
5.5), the IVBA of other metals known to adsorb on iron oxides and oxyhydroxides may also be 
similarly affected by microbial activity. These results indicate the use of IVBA results that don’t 
account for colon microbial activity may systematically underestimate health risks from the 
ingestion of metal contaminated soil. In contrast, the ability of GI microbes to decrease Hg 
IVBA from foods indicates that neglecting to include microbial activity into estimates of Hg 
IVBA activity may overestimate health risks from dietary Hg.  
In vitro GI microbial activity altered the speciation of Hg from traditional country foods 
(Figure 3.1) but did not affect the speciation of As from contaminated soils. For example, GI 
microbes decreased the proportion of bioaccessible Hg as MeHg up to 100%, perhaps due to 
microbial demethylation of MeHg in the country foods. This observation is in agreement with 
previous in vitro (Ludwicki 1990) and in vivo (Rowland 1980) research. In contrast, GI microbial 
activity was not responsible for the transformation of AsV to the more acutely toxic AsIII 
(Figures 5.4 & 5.5). Additionally, the incubation of As contaminated Hoboken soils with GI 
microbes did not lead to the formation of methylated arsenicals. This observation is in stark 
contrast to a recent publication that demonstrated substantial in vitro biotransformation 
(including biomethylation) of As from sodium arsenate and contaminated soils (Van de Wiele 
2010). The discrepancy between these studies may be due to differences between the GI 
microbial communities obtained for each study. Alternatively, the discrepancy could be due to 
differences in soil properties or could be a function of the lower As concentrations present in the 
Hoboken soils.  
The toxicological relevance, however, of the microbially-mediated changes on As IVBA and 
speciation may be dependent upon such effects being reflected in contaminant RBA. Or, in other 
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 words, metal contaminants mobilized by GI microbial activity must be subsequently absorbed 
across the intestinal epithelium (i.e., bioavailable) for the microbial effect to be important to the 
calculation of ingestion exposure. Consistent and significant microbially-mediated effects on As 
IVBA were only observed under simulated colon conditions (Figure 4.2, Figure 5.1, Figure 
5.2); however, the colon is not the primary site of As absorption (Otani 1957). In contrast, 
microbial activity under simulated small intestinal conditions, the primary site of As absorption 
(Kayne 1993; Otani 1957), caused only slight and transient effects on As IVBA (Table 6.2) and 
no effects upon As speciation. Furthermore, a juvenile swine study in which animals were orally 
exposed to soil-borne As with and without co-administration of oral antibiotics indicated that GI 
microbial activity does not effect As RBA (Table 6.5). These in vitro and in vivo results provide 
the strongest evidence to date that, contrary to the hypothesis of this thesis, GI microbial activity 
may be irrelevant to the actual bioavailability of ingested arsenic and hence irrelevant to the 
calculation of As IVBA. However, the ultimate importance of GI microbes to the estimation of 
ingestion exposure and consequent health risk cannot yet be dismissed since pre-systemic 
biotransformation of ingested As is not observed for all soils (Van de Wiele 2010). Thus, the 
results from the juvenile swine study reported herein may have been specific to the contaminated 
soil used in the trial and should not be extrapolated to other test materials or contaminated site 
risk assessment in general.    
Previous research developing in vitro GI models for the measurement of contaminant IVBA 
has largely proceeded on an ad hoc basis one contaminant at a time. Therefore, although there 
exists extensive peer-reviewed literature describing the IVBA of ingested As and Pb, this 
information cannot be applied to other contaminants of concern. One recent publication 
demonstrated that the IVBA of PAHs from contaminated soils was correlated with the Zwater (i.e., 
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 fugacity capacity of water) for each individual PAH (Siciliano 2010). Similarly, metal IVBA was 
strongly correlated with the water exchange rate constant (kH20ex) for each individual metal 
(Figure 7.4). These studies represent the first attempts to correlate IVBA with fundamental 
chemical properties of the contaminant of concern and offer tremendous potential for the 
development of predictive models (e.g., Table 7.7) of contaminant bioaccessibility. It is notable 
that the determining factor of PAH bioaccessibility (i..e., Zwater) is a thermodynamic-based 
variable (Reichenberg 2006) whereas the determining factor for metal cation bioaccessibility is a 
kinetic-based variable (Burgess 1999). None of the thermodynamic-based stability constants 
seen to be determinants of metal enrichment (Siciliano 2009) were important factors for metal 
IVBA from the Iqaluit soils. This suggests, for the soils included in these studies, that steady-
state and equilibrium may be more readily achievable for the dissolution processes of lipophilic 
organic contaminants such as PAHs than for metal cation contaminants. It remains to be seen 
whether this principle will hold true for other contaminants in soils from additional sites. 
8.2 Future Directions 
Future studies of metal IVBA from contaminated soils and foodstuffs should better 
characterize the speciation of the bioaccessible metals since the toxicokinetics and 
toxicodynamics of some metals are dependent upon speciation (Clarkson 2006; Cohen 2006; 
Denys 2008). For example, only a small fraction of HgII, between 7 and 15% (ATSDR 1999), is 
absorbed across the GI epithelium into systemic circulation via a dose-dependent and saturable 
mechanism (Hoyle 2005). In contrast, both human and animal studies indicate near complete 
(~95%) absorption of ingested MeHg (ATSDR 1999). The higher bioavailability of ingested 
MeHg is due to its absorption via an energy dependent active transport mechanism based upon 
its structural homology, when complexed to cysteine, with methionine (Clarkson et al., 2007). 
Similarly, the absorption efficiency, metabolism, and genotoxicity of ingested As is dependent 
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 upon the speciation of the bioavailable As (ATSDR 2007; Cohen 2006; Vahter 2002). For 
example, inorganic arsenate in drinking water is nearly completely absorbed into systemic 
circulation(ATSDR 2007) whereas at most 85% of an ingested dose of methylated arsenicals 
(MMA or DMA) is absorbed (ATSDR 2007). Not only are these methylated arsenical differently 
absorbed than inorganic arsenicals, but also they are differently metabolized (Cohen 2006). 
Furthermore, the toxicity and reactivity of the trivalent methylated arsenicals formed by colon 
microorganisms (Van de Wiele 2010) in the intestinal lumen may pose health risks (eg. colon 
cancer) even without absorption into systemic circulation. Consequentially, the IVBA of 
ingested HgT and As, as presented in the research herein, is of limited value to risk assessors 
when the bioaccessible metal is present as a mixture of species with varying toxicological 
profiles. Therefore, future calculations of Hg IVBA should calculate both HgII and MeHg IVBA 
separately while As IVBA should differentiate between inorganic As and trivalent methylated As 
metabolites. Similarly, IVBA estimates for several other metals (eg., chromium and nickel) 
should also characterize the percent contribution of each metal species present in the 
bioaccessible fraction since metal speciation will determine the TRV used in the human health 
risk assessment of contaminated sites (Health Canada 2004b). It must be noted though, that the 
utility of speciation data for the bioaccessible fractions of some metals and metalloids (e.g., 
arsenic and antimony) is contingent upon further toxicological research enabling the definition of 
TRVs that account for variations of the toxicity of differing metal species. 
Evaluations of contaminant bioaccessibility in the colon stage of the Simulator of the Human 
Intestinal Microbial Ecosystem (SHIME) do not as of yet account for inter-individual variation 
in the composition of GI microbiota. For example, current SHIME techniques for measuring 
contaminant bioaccessibility are conducted in triplicate by removing three aliquots of microbial 
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 suspension obtained from the dynamic SHIME (see Section 3.2.2). However, the microbial 
community cultured in the colon stage of the SHIME was derived from a single human fecal 
sample that is not necessarily representative of the enteric microflora of other individuals or 
populations. Since the GI microbial community used in the SHIME was obtained from a fecal 
specimen provided by an individual with a typical western urban diet (dominated by cereals, 
legumes, dairy products, fruits, vegetables, and meat), it is unknown whether the results obtained 
are relevant to the receptors of the risk assessment (i.e. Inuit adults and children). Thus, future 
studies investigating the role of GI microbial activity on Hg IVBA should utilize fecal samples 
collected from an Inuit volunteer with a traditional diet rich in country foods. Additionally, 
bioaccessibility studies using the colon stage of the SHIME should be repeated using fecal 
specimens obtained from several individuals. This strategy will provide researchers with 
information regarding the consistency of microbial effects upon metal bioaccessibility between 
individuals with varying diets, ages, and genders. 
Before estimates of contaminant bioaccessibility can be used in human health risk assessment 
they must be validated against accepted in vivo protocols (Casteel 2001; US EPA Region 8 
2005). The necessity of these validation studies is no less imperative for in silico predictive 
models based upon fugacity and/or metal lability than they are for in vitro models like the 
SHIME. In addition, future work must evaluate the mechanisms by which soil properties and 
mineralogy interacts with kH20ex before it will be possible to conclude whether metal IVBA may 
be predicted according to its lability without the prior knowledge of the bioaccessibility of 
another metal from the test material. Thereafter, the completion of in vivo validation studies will 
facilitate the use of concepts such as fugacity and metal lability as predictors of AFGIT for human 
health risk assessment. Additionally, the importance of enteric microbes to the calculation of 
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 metal bioaccessibility should be further investigated for a larger variety of test materials using in 
vivo validation studies of IVBA with and without GI microbial activity. 
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